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Part I 
Introduction and Review o/literature 
Based on: 
D. Tibboel, T. Okazaki, T. lvliyano: The Lung in Congenital Diaphragmatic Hemia 
(CDH); Do we Really Understand? 
in: Tibboel D, v.d. VOOlt E (editors) (1996) Intensive Care in Childhood; a Challenge to 
tlle Future Springer Verlag, Berlin 
ISBN #: 3-540-61130-4 
Chapter 1 Introduction 
Chapter 1 
1.1 Introdnction 
Growth and development are nmdamental processes and understanding of the mechanisms 
resulting in abnonnal growth and development fonn the core of pediatrics and pediatric 
surgery. 
ivIany acute problems in the perinatal period mise from premahlrity and congenital 
anomalies. AWlOugh mOltality is steadily decreasing due to progress in h'cahnent 
modalities and prenatal diagnosis, remaining life-long morbidity is increasingly impOltanL 
hI many of these children such as premahu'e newboms witll respiratOlY dish'ess syndrome 
(ROS), abnOlmal pulmonary development in case of congenital diapluagmatic hemia 
(CDR) or oligohydrarmuos associated with prolonged mphlre of membrarles arId renal 
anomalies (the so called Potter sequence) the lungs are the tar'get orgarl for treatment. 
1.2 Pathological aspects ofCDH 
It is generally accepted that the lung at the side of the defect in COH is hypoplastic, 
although large variability exists in tlle amount of hypoplasia. The sarlle holds tllrough for 
tlle conh'alateral lung. Shuctural charlges have been demonstrated in the puhllonary 
parenchyma of CDn patients such as delayed matmation of alveolar' stmctmes arId a 
decreased number of bronchial brarlches [1,2]. At routine pathology a sigtuficarlt lower 
hmg hodyweight ratio « 0.012) and a decreased radial alveolar' COlUlt (RAC) are conunon 
denominators of pulmonmy hypoplasia. 
Botll in spontaneous InulIml cases, as in experimentally induced con in a var'iety of 
arumal models, contradictOlY results have been published related to tlle nlllctional 
maturation of the Ilmg in CDR In the humarl tllese data me eitl,er based on measurement 
of smfactmlt components derived liOln bronchoalveolar lavage fluid [3] or consecutive 
lccitlun,lsphingomyelin (LIS) ratio in prenatally diagtlOsed congenital diaphragmatic hemia 
patients with or without polyhydrarllluos [3,4,5]. Prenatalulh'asOlllld to predict the amount 
of pulmonary hypoplasia has not revealed simple measurements. Hanison et al. published 
a repOlt on 44 fehlses with COH, using a combination of sOllOgt'apluc pm'arneters 
(lung/head ratio two dimensional area of light hmg at tlle level of the right atrium ,I head 
circlUnference), which looked promising [6]. 
The strllctural chmlges in tlre lungs of con patients, are not rcsh'icted to the respiratOlY 
unit. WeB determined pulmonary vascular abnonnalities are present as welL TIlese consist 
of a decrease in total size of tlle pullnonmy vasculm' bed, increased tluckness of thc 
pulmollmy m1erial smootllllluscle coat, a decreased number of vessels per unit of lung and 
arl increased thickness oftlle adventitia.[7-9] 
1.3 Clinical Consequences 
One of the major problems following buth of a child witll CDn is to predict outcome. The 
charlged attitude towm'ds timing of the operative repau' of the diaphragtnatic defect has 
revealed decreased eompliarlce followulg repau' of the diaphragtn [10-12]. But an absolute 
value of compliarlce predicting 100% mOltality is not available. The smne holds tllrough 
for the reaction of tlle lung on attificial ventilation for which a vmiety of treatment 
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modalities has been proposed to influence outcome ranging limn gentle ventilation, high 
liequency oscillation with or without nih'ic oxide and extracOlporeal membrane 
oxygenation with or without partial liquid ventilation [13-19]. 
Partial liquid ventilation is the latest Olerapeutic modality, No prospective randomized 
h'ials are available today on any of these treannent modalities proving one to be supelior 
compared with other treatments, However we do know O,at following conventional 
miificial ventilation a high incidence of chronic hmg disease in telm bam infants with 
CDH is doclUnented [20]. 
1.4 Animal Models for CDR Mimicking the Human Situation 
Various animals are used for surgical induction ofCDH; the lamb is the most widespread 
used, but also monkeys mld rabbits have been tested [21-25]. 
The timing of CDH induction in lambs is, as in rats, important; the em'lier in fetal life the 
lesion is produced the more severe the hypoplasia, Because tIus model is based on 
penetration of a balloon or bowels through ml already closed diaphragm technical 
problems restrict the em'liest possible intervention, Adzick et al. created CDH in lambs at 
gestational day 60-63, In the lamb it is possible to cvaluate hemodynamics mld the 
influence of ventilation on blood gas values and morphology, Moreover the CDH lamb is 
surfactant deficient [26]. In the smne model Wilcox ct al. repOlted on Ole effect of 
exogenous smfactant replacement tIlerapy on gas exchange; both lung mechmucs and gas 
exchmlge improved markedly [27]. 
Hmlison's group used the lamb model to shldy pulmonmy hypoplasia tIlat accompmues 
CDH and the possibility of reversing these chmlges by conecting the diapln'agmatic defect 
in utero, In their view fetal therapy is the logical consequence of progress in fetal 
diagnosis, Tlus influenced the ideas of HmTison's group on the emblyological aspects of 
CDH: pulmonmy hypoplasia was caused by migrated bowels during fetal development 
and could be conected by retracting these loops out of the tIloracic cavity in ml as earliest 
possible stage of development. The lungs will show a compensatOlY groWtIl which will 
beneficially influence smvival. The results of the mumal experiments conducted by 
Harrison et ai. proved, at least patti ally, their ideas. In the meantime patient selection 
proved to be very difficult while no sigtrificant overall improvement of slUvival was 
documented based on a NIH sUPpOlied tIial of fetal correction in Ole human (28,29), 
PUlmOllaIY hypoplasia in humans can also be associated with other anomalies such as 
renal dysplasia mld oligohydrmmuos, Animal expeliments in sheep revealed a relation 
between pulmonmy fluid dynamics and pulmonmy gt'Owth [30-32]. Tracheal ligation in 
tIle fetus accelerates lung growth beyond normal linuts, even in tIle absence of kidneys 
[33-35]. Ligation of tIle h'achea, tI,e so-called PLUG tecluuque, ofCDH lambs during fetal 
development, resulted in an improved sUlvival of tIle lamb with CDH after birth [36,37], 
Tilis plugging is considered to provide a less invasive way of intra-uterine CDH treatment 
but negative effects on type II cell differentiation have been reported as well [38]. 
AltIlough at least 20 successful cases in tIle humml have becn described, it is too early to 
judge upon O,is tI'eatment modality, One has to realize that shmn operation irl tI,e fehls has 
an adverse effect on lung growth resulting in a significant decrease in DNA, protein and 
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satmated phosphatidylcholine, but no significant change in lung volume [39]. 
In the rat model of CDH the lungs are biochemically immature or hypoplastic with regards 
to DNA and phospholipid levels but not in antioxidant enzyme activity [40-41). Also 
morphologic measurements show hypoplasia: lowered lung weight, volumes and radial 
saccular count or immaturity, Using imnnUlohistochemisby a retarded differentiation of 
cuboid type II cclls into squamous type I cells was shown [42). 
Whether these animal models really conuibute to tile understanding of the morphological 
and umctional abnonnalities of the lung in CDH remains questionable. 
The rat model of CDH enables investigators to study the natural histOlY of the defect. 
Moreover tile biochemical matmation of tile itmg at different stages of development, Witil 
respect to type II cell differentiation, sUtfactant levels, anti oxidant enzyme activity, 
neuroendocrine cell body (NEB) disu·ibution, nitric oxide syntilase activity as well as 
eicasenoid levels has been investigated. The sequence of events related to the primary 
auomaly (diaphragmatic defect of pulmonary hypoplasia) in CDH is also investigated in 
tills modeL However it is velY hard to pelfonn intelventions which mimic the clinical 
situation in the humarl, although short periods of artificial ventilation ar·e possible [43-46). 
In contrast to tile rat model the sheep model offers great advantages in studying the 
patilOphysioloh'Y of the lung and pulmonary vessels dilling different tilerapeutic 
intelventions following birth [47]. M'\ior differences exist between the itmg developmental 
pattelll in tile sheep arId the Illtman while titis animal model does not provide arry insight 
into the patilOgenesis of the defect or tile naturalltistOlY of the lung in CDH. Very rew 
comparative studies are available in lnunan cases of CDH describing slIlfactant levels, 
eicasenoid levels in BAL fluid, neuroendocrine body (NEB) distribution etc. ([48, 49]. For 
a better understanding of the specific aspects of the abn0l1llai lung in CDH, a 
developmental biological approach is vety impOltant as well as studying the effects of 
l'sb'ess" on the abnonnallung. 
1.5 Developmental Biological Aspects of the Lung 
Epithelial brarlching is one of the mllior events in lung 111011lhogenesis. The brarlciting 
process depends on tile interaction of the epitilelium witil the mesenchyme. The amount of 
mesenchyme as well as its source (lung versus nOll-lung, tenninal versus proximal) is 
shm\1l to be of impOltance in a number of studies [50-53). 
1.6 The significance of the mesenchyme 
It seems likely that mesenchyme SUppOlts the morphogenesis and differentiation of tile 
respiratOlY epitilelillln in part tilrough the type of matrix tilat it synthesizes arId deposits 
[54]. Among the components of tile exu·acellular matrix that have been indicated as being 
necessary for branching ar·e collagens III arId IV, fibronectin and laminin [55-61]. Schuger 
et aJ. described that both hmg epitilelium and mesenchyme produce complete laminin 
molecules, shown by immunoltistochemistry and in situ hybridization studies [62]. 
The expression of extracellular· matrix components, transcription factors, growth factors, 
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and nemopeptides has hardly been studied in regard to the pathogenesis of abnonnallung 
development in CDH. The abnollnal number of ainvay generations in the lung in CDH 
suggests a distmbed pattem of branching mOll'hogenesis. However, it is not clear whether 
insufficient epithelial-mesenchymal interaction or insufficient stimulation by b·anscription 
factors or substances such a bombesin-a neuropeptide with growth factor-like 
propCliies---{:ontibute to this featme. Immunohistochemical findings in Nitrofen-exposed 
rats indicate that the expression pattem of fibronectin, laminin, and collagens III and IV is 
not different between CDH and conh"Ols from gestational day II until day 21 (A.E. 
Brandsma, personal commlllllcation). In lungs of CDH rat pups, the expression of thyroid 
hOllnone receptors in the ipsilateral and conlralateral lungs is similar to that of lungs in 
conh·ols at all stages shrdied. 
The expression of nemopeptides in CDH has been evaluated in only a few cases. In the rat 
model of CDH, increased calcitonin gene-related peptide (CORP) inununoreactivity has 
been repOlted in pulmonary neuroendocrine cells towards the end of gestation, whereas a 
delay in CORP expression was found on gestational day 18. In lungs of one infant with 
CDH the expression of gash·in-releasing peptide was lower than in gestational age-
matched conh·ollung. Increased bombesin immunoreactivity is documented to be present 
in lungs of some infants with CDH compared with infants with hydroplastic lungs due to 
other causes and conn.-ols, 
1.7 Hormonal Effects on Lung Development Relevant to CDH 
It has long been known that thyroid hOlmone and glucocOliicoids influence pulmoll!uy 
development, especially type II cell differentiation. 
Because thyroid hOI1none acts via its receptors, it is necessmy to demonstrate the tissue 
localization of the (nuclear) tll)"·oid hOlmone receptor (TER) in early development. The 
spatio-temporal expression of the different isofol1ns of THR mRNAS bOtil in the 
developing rat and ll10use have been studied, using in sihr hybridization techniques. 
In rat TERalpha and TERbeta mRNAS were fn·st detectable at embrYOlllc day (ED) 13 
and increased in cellular concentration up to ED 18, i.e. 4 days before birth, when organ 
mahrration has come to proceed rapidly. TI-ill-alpha is exclusively present irl the 
mesenchyme. After ED 18, THRRlpha and THRbeta mRNAS gradually declirle so that by 
1 week after birth, bOtil receptors have reached tlleir definitive (adult) levels. (Keijzer, 
unpublished results) 
In botllll10USe and rat, an expression comparable to that of tile THRs was found for one of 
tire partners of tile THRs Witll which tlley from heterodirners, tile 9-cis retinoic acid 
receptors (RXRs), RXR-alpha beirlg concentrated irl the developing epitlreliun) and RXR-
beta in tile supporting mesenchyme of the lung. 
The impOltance of tll)"·oid horlllone for pulmonary development arId the st11lchrral 
resemblarlce of Nitro fen and thyroid hOlmone OIiginated resear·cll into a possible inhibition 
of T3 receptor-bindirlg by Nitrofen showing a non-competitive inhibition at rcceptor level 
[63]. 
Subsequently the spatio-temporal expression pattem was investigated of the TER, OCR 
(glucocorticoid) and RXR (retinoic acid) receptor during abnormal pulmonary 
5 
Chapter I Introduction 
development following induction of CDH by Nitrofen, No differences were observed 
suggesting that abnonnal development is not mediated by a change in receptor expression 
in the developing hUlg, In other words, differences in expression pattem of thyroid 
hormone receptor cannot be held responsible for the abnonnal development of the lung in 
CDR. 
Amongst the other known growth faetors in the developing rat lung, mRNA expression of 
all components of the IGF system, (IGFs, IGFBPs and the type I IGF receptor) have been 
repOlted [64-67]. In addition, gene dismption strategies have demonstrated that both IGFs 
and the type I IGF receptor are indispensable for nonnal emblYOluc and posomtal growth, 
Type I IGF receptor mutants and some IGF-I mutants died at birth of respiratOlY failme 
[68]. This suggests that these proteins may participate in lung development in a paracrine 
or autocrine way. 
1.8 Vasculal' Development in CDH 
From a pathological point of view the morphological abnOllllalities in the puitnonary 
vasculaou'e ar'e well doclUnented (7,8,9), The question remains whether these 
morphological features ar'e directly conelated to the response of the pulmonary vasculature 
on hypoxia, metabolic acidosis and other so'essfhl events, Moreover the reaction on the 
variety of vasoactive dl'llgs including inspiratOlY NO-therapy used in a clinical practice is 
luglily unpredictable, 
Much attention has been paid to the increased muscular coat observed at bilth arId the 
peripheral extension of the muscularity in CDH [7,8]. In contrast detailed descriptions on 
the development of the vasculature in CDR are almost 110n existing. This means that no 
direct conelation carl be made between a well char'acterized stage irl development irl which 
tlus type of muscular'ization is a normal feaou'e and the mOlllhology of the pulmonary 
vasculahtre in CDB. In other words, vascular balance with regards to tone of the vessel 
wall is hardly understood, It is unceltain whether tile described abnOllllalities in tile CDH 
lung represent a developmental delay only, 
For the development of the blood vessels in the lung, angiogenesis and vascnlogenesis ar'e 
impOltant mOll'hogenetic processes [69]. A close cOll'elation is observed between tile 
development of ti,e airways arId arteries, The synchronization of airway arId vessel 
branches suggests tllat tI,ere is a response to connnon mediators or tI,at tlleY exchange 
messenger molecules [for review, see 70]. 
Following the initial stage of angiogenesis and vasculogenesis, control of vascular 
proliferation is detelmined by the local production arId action of a variety of groWtll 
factors. 
In this context TGB-beta I; ti,e platelet derived b~'owth factor receptor ligarld system arId 
the insulin-like grOWtll factors (IGFs) have been doclUnented especially irl irl vio'o culolre 
systems as well as in tissue sections usirlg irl situ hybridization tecllluques arId RT-PCR, 
Much interest is directed nowadays towar'ds vascular' enclotllelial growtll factors (VEGF), 
one of the potent angiogenic factors, Its mitotic activity is restricted to vascular 
endothelial cells in contrast to otllers such as TGF, PDGF arId IGF [71,72]. VEGF is an 
impOltant regulator of endotllelial cell proliferation durirlg the extensive tissue growth and 
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remodeling that occurs in utero [73]. In addition, hypoxia has been shown to be a potent 
inducer of VEGF expression implicating its direct role in hypoxia mediated angiogenesis 
[74,75]. Regarding the role ofVEGF in abnonnal vascular development in the CDR itmg, 
however, no studies are available so far. 
Besides endothelial cell growth, n011nal vascular development consists of the development 
of a muscular coat represented by smooth muscle cells and extracellular matrix. The 
smooth muscle cell is essential for the development of vascular tone. Especially the group 
of Stenmark has conuibuted to the Illlderstanding of the interaction between the medial 
smooth muscle cells and the exu·acellular mauix using the high altitude calf as an animal 
model to study the cell biological features underlying pulmonmy hypertension, review 
StelllllaI·k [70]. 
Smooth muscle cells do contain different forms of myosin heavy chain molecules. Tn a 
number of species, including rabbit, rat mid human, at least three types of MRC m·e 
isolated. Using cDNA probes mid isofoI1n specific isofo11ns Sml (204kD), SM2 (200 kD) 
and SM embryo (200kD) are known to be developmentally regulated [76]. It is of 
relevance to study the expression pattern of these isofonns during abnonnal itUlg 
development in CDH. Although the mOlphological abnOllllalities in the pulmonmy 
vasculm· layers have been documented, it is not known which development stage of 
vascular musculm· differentiation the lungs ill CDR represent. Following the descdption of 
mOlphological chmlges in the developing pulmollmy vasculature, more recently the role of 
growtll factors has beell investigated, especially tile fmnily of fibroblast growth factor 
(FGF), u·ansfonning growth factor [3 (TGF- (3) and isofo1111S of platelet dedved growtll 
factor (PDGF). tlris chapter for detailed description. 
Two mOlphogenic processes conu·ibute to the development of the lung vasculature: 
vasculogenesis and angiogenesis [77-82]. In vasculogenesis, blood vessels develop de 
novo. The pre-existing endothelial cell precursors or angioblasts fonn primitive 
vascular chamlels, which subsequentlly remodel so that arteries, veins and lymphatics 
are produced, depending on local stimuli from the sUlTounding mesodenll [77-81]. In 
contrast, in angiogenesis, blood vessels develop from pre-existing ones by a process of 
budding and sprouting [78,79,81]. Angiogenesis is thought to be responsible for the 
fonnation of axial arteries [78, 81]. 
The stmcture of tile puhnonmy arteries varies with vessel size mid developmental stage of 
tile lung. The muscular coat of the artery firstly becomes appar·ent in the canalicular stage. 
Axial arteries from the hilum to the 7th generation m·e elastic; more peripheral arieries are 
muscular, prutial muscular or, at the level of intraacinar mtelY, predominantly non-
muscular. By definition, an elastic artery has more titan two elastic laminae in its media, 
while a muscular artery has only two elastic lmninae [81-82]. A partially muscular· artery 
has smooth muscle cell tissue in only one part of its circllluference; at tlris level the 
continuous muscular coat has been replaced by a spiral of smooth muscle cells (SMC). A 
non-muscular arielY (arteriole) is similar in stl1lcture to arl alveolar capillary, except for 
(Iargcr) diameter [81,82]. Small muscular alld probably tile partially muscular arteries 
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represent the -so called- resistance arteries, Muscularization decreases towards the lung 
periphery in the nonnal fetus. A newbol1l has one mtery for every 20 alveoli. In humans, 
due to fonnatiou of new alveoli poslnatally, this ratio is reduced to 8: I [81-83). 
Two Iypes of pulmonary arteries can be distinguished: axial arteries, which accompany 
airways and additional or supennllneraty arteries. The latter are smalllaleral brarlches that 
arise Jimn axial arteries and nUl a short course to supply the capillary bed of alveoli 
immediately adjacent to the puhnonmy mtelY at d,e peribronchial parenchyma [80]. The 
latter are considerably more numerous and contribute in a significant way to the cross-
section of the total recmited vascular bed. Supennnllerary arteries constitute about 25% of 
the cross-sectional area at preacinar level, whereas at the intraacinar level they make up 
about 33%. According to Hislop arId Reid in the nOll1lallung, there are 23 generations of 
conventlonal m1eries along the posterior basal axial pulmonmy miery branch with 64 
supenllnnermy branches, giving a ratio of 1:2,8 between conventional and supemumermy 
arteries for one axial branch [77,83). Supel1lumerary arteries facilitate blood oxygenation 
by allowing passage of venous blood to d,e more remote alveoli adjacent to large mteries, 
veins and airways [80,83,84). The intraacinar arteries represent an important part of the 
resislance arieries in dIe pulmonary vascular bed. The extemal dimneter (ED) of pre acinar 
arteries usually exceeds 200 ,rm; while d,e arteries nlllning with the respiratory bronchioli 
represent dIe intraacinar' arteries and have a ED of 50-200 11m [85). These intraacinar 
m1eries together with the supenmmermy m1eries increase rapidly in number and dilate 
near' term to accommodale the postnatal demands of d,e pulmonary circulation [85,86). 
1.9 Stress and Injury in the Developing Lung 
Prolonged exposure to hyperoxia and barotrauma causes acute hmg injury that leads to an 
inflammatOlY reaction, The initial phase of the iqjmy process is chm'acterized by an influx 
of cells, mainly neutrophils and an elevation of the release of various inflammatOlY 
mediators [87). This early inflammatory phase is followed by a subacute fibroproliferative 
rcsponse with fibroblast and smoodl muscle proliferation, this leads to interstitial and 
perialveolar fibrosis [88). Recent cvidence snggesls d,at d,e fibroproliferation response 
may be due to exaggerated expression of dIe fibroproliferation cytokincs snch as platelet-
derived groWdl factor-BB (PDGF-BB), transfollning growt factor-Il (TGF-Il) and 
interleukirl lb by locally accumulated alveolm' macrophages and probably epithelial cells 
[89-91). In some cases the inflammatory and fibroproliferation response can lead to 
development of chronic lung disease (CLD). 
The potential role of inflammation and infection in d,e process of CLD is suggested by 
cylological, hislopadrological and clinical studies [92-94]. Several of these studies show 
that artificial ventilation or ECMO trealment lead to a high incidence of CLD, which 
occuurs mainly in premalurely bam infants with respiratory distress syndrome (RDS) arId 
smiactarlt deficiency. CLD has been described in 33% of d,e CDH survivors, despite a 
mean bit1h weighl of nem-Iy 3000 grams [20). Patients who are treated WiUI ECMO for 
respit'atory insnfficiency have an 11.5 -fold itlcreased risk for development of CLD, 
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especially when ECMO is struted 96 hours after buth [87,95]. 
Immaturity of the IIUlg, bru'otrauma and oxygen toxicity all contribute to the lung il,jmy 
and thepathogenesis of CLD, but tile exact mechanisms by which the lung undergoes 
severe dismption Ul stmcture and function is not fully ,mderstood. The same hold tme for 
mechanisms preventing lung il~Ury [20,87]. The ungoing tissue drunage can be diminished 
or prevented by a nmnber of molecules. Antioxidant enzymes (AOE) scavenge or detoxifY 
the highly reactive oxygen metabolites. In the rat model of CDR, AOE activities 
ulcreased gradually in nOlmal rat pups during 5 hours of rutificial ventilation but not in 
CDR rats. Another system of cellular defense mechanisms WIder stress are the so called 
heat shocks proteuls (HSPs). RSPs are a group of highly conselved proteins that Crul be 
induced by a vruiety of pathophysiological phenomena such as hypoxia, oxidatives and 
metabolic stress [96-99]. We ru'e not fully aware of the exact mechanisms of the cellular 
defense system under stress in nonnal and CDH hUlgs. 
1.10 Concluding Remarks 
Many questions are unanswered at tltis moment. The significrulce of growth factors 
revealed by NOlthem blot analysis or differences in distribution pattem as shown by Ul situ 
hybidization or immlUlOhistochemisl1y are hard to interpret eitller as cause or consequence 
of abnonnallung growth. The same holds true for tile effects of hOlmoncs, especially the 
siguificrulce of tll)"'oid honnone for (nOlmal) lung growth, and differentiation of type IT 
cells Ul pruticular. The trrulsgenic ntice models such as (conditional) knock out mutants for 
different gcnes relevrult for lung development, such as THR alpha and tire different 
smfactant proteuls (surfactrult protein B) are experimental approaches nowadays 
perfonned in different laboratories. In the meantime experimental application of honnones 
like cmticosteroids leads to an ulcrease in SP A levels. Consequently prospective 
randomized trials are Ul tile last phase of prepru'ation evaluatulg tire effect of prenatal 
admutistration of cmticosteroids following prenatal diagnosis of CDR in lnunruls. 
The release of vasoactive snbstrulces and tile unpredictable reaction of tire pulmonruy 
vessels on inhaled ltitric oxide is hardly wlderstood. Whether the hUlgs are primarily 
abnmmal in their vasoactive response or tllese responses result finm tile UISUIt of tile lung 
during artificial ventilation is lru'gely unknowll. 
Moreover, tile significance of the described patllological features and the translation 
towards fiUlctional abnonnalities is unclear. Especially the wlderstanding of tile reaction 
of the lung following the "UlSlllt" of pre or postnatal trcaonent modalities, such as different 
fmms of altificial ventilation, tile application of vasoactive drugs ruld the operative 
procedure is hardly investigated. 
1.11 Specific Aims 
The specific auns of the sOldies described in tltis tllesis are: 
I. to investigate differences in pulmonmy vascular development between healthy and 
CDH lungs (chapter 2,3). 
2. to investigate the expression pattems of vaso~active mediators in CDR hUlgs; in other 
9 
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words "pulmonmy vascular balance in CDH" (chapter 4). 
3. to evaluate the effects of "insults" such as new fonns of mtificial ventilation ("pmtial 
liquid ventilation") mId exogenous stimuli (NO, exposme) on stress response in 
neonatal heaWlY mId CDH hurgs (chapter 5,6). 
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Pulmollary Vascular Development 
Chapter 2 VEGF in Rat CDR 
Chapter 2 
The Role of Vascular Endothelial Growth Factor and Myosin Isofonns 
during Pulmonary Angiogenesis iu a Rat Model of CDH 
Based on the article: 
Okazaki T, Sharma HS, Aikawa M, Yamataka A, Nagai R, Miyano T and Tibboel D: 
Pulmonary expression of vascular endothelial growth factor and myosin isofonns 111 
rats with congcnital diaphragmatic hernia. J. Ped. SlIIg 32 (3): 391-394,1997 
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2.1 SUlllllUtry 
Abnormalities of the pulmonmy vasculature are well documented in congenital 
diaphragmatic hernia (CDR). Vascular endothelial growth factor (VEGF), a novel 
angiogenic factor, is a recently described endothelial cell specific growth factor. 
Myosin heavy chain (MRC) isofo11ns such as SMemb, SM! and SM2 are important 
molecular markcrs to study vascular muscle cell differentiation. SMemb is expressed 
only in immature smooth muscle eells(SMC), while SM2 is expressed in mature SMCs. 
W c investigated the expression of VEGF and SMC differentiation in pulmonary 
vessels in CDR rat lungs and controls. The lungs of Nitrofen induced CDH rat fetuses 
(N~16, gestational age E16, E18, E20, E22) were stained immunohistochemically 
using antibodies against VEGF, SMemb and SM2, while alpha-actin was used as a 
general marker of smooth muscle. 
In the CDR group VEGF expression was negative in pulmonmy vessels before birth, 
while in the control group VEGF was positive in smooth muscle cells in vessel walls 
from E20 in both vessels at the hilum and in pulmonmy parenchyma. In both control 
and CDR groups SMemb expression was positive from E 16. SM2 expression was 
negative in vessel walls during the prenatal period in both groups. Alpha-actin was 
determined both in control and CDR lung in the lung hilum from E 16 and around 
peripheral vessels from E 18. Differences in vascular smooth muscle cell differentiation 
were not observed between control and CDR lung. These findings suggest that 
differences in pulmonmy vascular development exist between control and CDH rats for 
VEGF cxpression, while maturational differences in smooth muscle cell differentiation 
are not present. This role of altered endothelial cell growth might be related to the 
different puhnonmy vascular reactivity present in CDH lungs. 
2.2 Introduction 
Congenital diaphragmatic hernia(CDR) is a serious anomaly with a high mortality and 
morbidity due to the presence of pulmonmy hypoplasia and pulmonaty 
hypetiension!,2. The high mOliality rate of 40 to 50 % has not changed significantly 
during the past decennium despite changing concepts in treatment such as delayed 
surgety, nitric oxide and ECM03,4, As pulmonary vessel abnormalities are ,vell 
documented in CDH2, recently several investigators have examined vasoactive fhetol's 
such as endothelin5 and nitric oxide synthase6 in CDH. However, detailed descriptions 
on the natural histOlY of pulmonary vascular development, especially in the embtyonie 
and fetal phase, are not existing. 
Vascular endothelial growth faetor(VEGF), a novel angiogenic growth factor, has been 
described since 1989 as a specific endothelial cell growth promoter7,8. It is an 
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impOltant regulator of endothelial cell replication during the extensive tissue growth 
and remodeling that occurs in utero9. Moreover, myosin heavy chain (MHC) isoforms, 
such as SMemb, SMI and SM2, are important molecular markers to study vascular 
muscle cell differentiation1O,1l,12. SMemb is expressed only in immature smooth 
muscle cells(SMC) while SM2 is expressed in mature SMCs. SMI is considered as a 
general marker of smooth muscle cells because it is constitutively expressed at all 
stages. 
Because the interrelationship of endothelial cell growth and SMC differentiation in 
pulmonary vessel development has not been studied in CDH so far, we examined the 
expression of VEGF and MHC isoforms immunohistochemically in a rat model of 
CDH. 
2.3 Matedals and Methods 
Experimental Animals 
Adult female Sprague-Dawley rats were mated ove111ight. Observation of positive 
smears was considered a proof of pregnancy (day 0 of pregnancy). To induce CDH, 
100 mg of2,4-dichloro-phenyl-p-nitrophenylether (Nitrofen) dissolved in Iml olive oil 
was given on day 10 of gestation 13. In control animals, the same dose of olive oil was 
given without Nitrofen. Water and food were supplied ad libihun during the whole 
period of the experiment. At gestational age 16 (E 16), 18 (EI8), 20 (E20) and 22 (tenn) 
(E22) the mother was anesthesizcd by inhalation of ether and cesarean section \vas 
performed. The fetuses were removed and killed before any breathing occulTed. Age-
matched normal fetuses were obtained from control animals. 
111111111/1 oil isfocllelll isflJ' 
The lungs from CDH and control fetuses (n~16 in each gestational age group) were 
fixed in a mixed solution of95 vol% ethanol 100% and 5% acetic acid 96%. They were 
embedded with paraffin and sectioned in 3-J.lm slices. Immunohistochemical studies 
were perfol111ed with inullunoenzymatic method. To reduce nonspecific reactions, 
sections were preincubated with 0.3% hydrogen peroxidase and normal goat serum. 
Antibodies (Ab) against VEGF (diluted 1:100), SMemb (diluted 1:200) and SM2 
(diluted 1:100) were applied as primaty antisenun. Antibody against VEGF was 
purchased from Santa Cruz Biotechnology Inc.(Gennany). Antibodies against SMemb 
and SM2 were developed by one of the authers from two oligopeptides specifying the 
carboxyl terminal end of SMemb (Thr-Ser-Asp-Val-Asn-Glu-Thr-Gln-Pro-Pro-Gln-
Ser-Glu) and SM2 (Gly-Pro-Pro-Pro-Gln-Glu-Thr-Ser-Gln) as described before12. 
Instead of SMI, alpha-actin (diluted I: 100) was used as primary antisenun because our 
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antibody of SMl stained negative with smooth musele in the rat. The slides were 
couterstained with hematoxyline solution. Negative controls were obtains by applying 
nonimmune goat SClUm in place of antibodies against VEGF, 8Memb, 8M2 and alpha R 
actin. The expression of these proteins were evaluated as positive (+) or negative (-). 
2.4 Results 
The results are summarized in Table I. In the CDR group VEGF expression was 
negative in vessel walls during fetal development (Fig I a), while in the control group 
VEGF was positive in SMCs around large and peripheral vessel walls from E20 (Fig. 1 
b). 
In both control and CDR animals SMemb expression was positive in large vessel walls 
in the lung hilum from El6 (Fig. 2) and in peripheral vessels from El8. SM2 
expression was negative in vessel walls during the prenatal period in both groups. 
Alpha-actin was detennined both in CDR and control lung in large vessels in the lung 
hilum from E16 and around peripheral vessels from El8. Differences in vascular SMC 
differentiation were not observed between control and CDR groups (Fig. 3). 
See color pictures ou page 122. 
Table 1. Expression of VEGF, 8memb, 8l\,12, find Alpha-Actin in Pulmonary Vessels in 
CDR and Control Rat Lungs. 
Day 16 Day18 Day 20 Day 22 
VEGF 
CDR 
Control 
Smemb 
SM2 
CDR 
Control 
CDR 
Control 
Alpha-Actin 
CDR 
Control 
+* 
+* 
+* 
+* 
+ 
+ 
+ 
+ 
* positive only in large vessels in lung hilium. 
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2.5 Discussiou 
Our findings show that differences in pulmonmy vascular development exist between 
control and CDH rats for VEGF expression from E20, while differences in expression 
of MHC isoforms, which are useful markers for SMC differentiation 10,1 1,12, are not 
present. So far several investigators 1,2,14w16 reported pulmonary vascular 
abnOlmalities in CDH such as an increase in muscle mass and decrease in the size of 
the pulmonary vascular bed. However, our results suggest that maturational differences 
in SMC differentiation are not present between control and CDH rats at least at MHC 
isofonn level. In addition, because SMemb and alphawactin expression are observed in 
large vessel walls from E16 and in peripheral lung fields from E18 in both control and 
CDH rats, these findings suggest that there is no differences in the developmental 
sequence of SMC differcntiation. 
VEGF is one of the potent angiogenic factors and it's mitotic activity is restricted to 
vascular cndothelial cells in contrast to others such as fibroblast growth factor (FGF) 
and platelet-derived growth factor (PDGF)17,18. VEGF is also impmiant in the 
regulation of angiogencsis during fetal devclopment. As VEGF is localized primarily to 
myocytes and epithelial cells but not to endothelial cells in the human fetus, it is 
considered that VEGF has a paracrine mechanism of action I O. Our result that VEGF is 
expressed in SMCs in vessel wall and in the airway epithelium (data not shown) from 
E20 in control rat lung is comparable with these findings. In contrast to control rat 
lung, VEGF cxpression is negative in CDH rat lung. This suggests that the differences 
of VEGF expression in prenatal vessels might play an important role in abnormal 
puhnonmy vascular development in the CDH lung. 
Recently some authors reported that inhaled nitric oxide (NO) improved oxygenation 
and decrease pulmonmy artelY pressure in experimental 19 and clinical20 cases of 
CDH. NO is a potent pulmonary vasodilator and it is produced by the enzyme nitric 
oxide synthase (NOS) in the pulmonary vascular endothelium. North et al.7 described 
that endothelial NOS mRNA in the lung was decreased on day 20 of gestation in the rat 
model with CDH. Our results suggest that an altered endothelial cell growth resulting 
in a different VEGF expression might form the background of a changed pulmonmy 
vascular reactivity in the absence of significant abnormalities of SMC differentiation. 
This also might be relevant considering the role of NO and NOS as modulators of 
pulmonary vascular tone. 
As the mode of action of VEGF is directed through receptor-affinity and at least two 
different receptors are identified21 ,22, further elucidation of the exact change of VEGF 
in abnormal lungs of CDH is warranted. 
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3.1 Sunllnar), 
Pulmonary hypoplasia accompanied by therapy resistant pulmonary hypertension (PH) is 
an important feature of congenital diaphragmatic hernia (CDH). The pathogenesis of the 
pulmonary vascular abnormalities in CDR remains to be elucidated at the molecular 
level. Vascular endothelial growth factor (VEGF), an endothelial cell specific mitogen, is 
known to playa role in pulmonary angiogenesis and vascular remodeling, hO\vever no 
data on VEGF expression are available in CDH patients. 
Twenty-one lung autopsy specimens of human CDH patients with lung hypoplasia and of 
seven age-matched control newborns without lung hypoplasia were processed for 
immunohistochemisny using affinity pudfied anti-human VEGF antibodies. All CDH 
cases had pulmonary hypoplasia, as evident from a lungfbody weight index:': 0.012 and 
pulmonary hypertension documcntcd by repeated cardiac ultrasound. Cellular 
localization of VEGF was semiquantitatively analyzed using a staining score ranging 
from 0 (no staining) to 4 (vcry su'ong staining). The results were statistically evaluated 
with accepted significance at P Icvel of:': 0.05. 
Significantly elevated levels of VEGF immunoreactivity were observed in CDH lungs as 
compared to the eonu'ols. VEGF was mainly detected in bronchial cpithelium and in 
medial smooth muscle cells (SMC) of large (> 200 fun) and small « 200 fun) pulmonmy 
arteries, with the most intense staining of the pulmonary vasculature in medial SMC of 
small pulmonmy m1eries. In CDH patients, but not in controls, endothelial cells were 
positive for VEGF staining. 
This is the first sUldy on VEGF expression in human CDH neonates, Elevated 
expression levels of VEGF, especially in the small, prcssure-regulating pulmonary 
arteries, point to a potential role in vascular remodeling. Perhaps this may reflects an 
unsuccessful attcmpt of the developing feuls to increase the pulmonary vascular bed in 
the CDH hypoplastic lungs in order to alleviate the associated pulmonary 
hypeltension. 
3.2 Introductiou 
Congenital diaphragmatic hernia (CDH) remains one of the m!jjor challenges in pcdiatrie 
surgety and neonatology. Despite recent developments in thcrapeutic modalities such as 
delayed surgelY, exogenous surfactant therapy, nitric oxide (NO) inhalation, 
extracotporcal membrane oxygenation (ECMO), and partial liquid ventilation, the 
mortality rate remains around 40% in high-risk cases'-3. The main documented 
pathological findings in CDH lungs are lung hypoplasia and pulmonary vascular 
abnormalities. The latter consist of: a) reduced total pulmonary vascular bed and 
decreased number of vessels per volume unit of lung, b) medial hyperplasia of 
pulmonat:l arteries together with peripheral extension of the muscle layer into small 
arterioles -6. The most common cause of the unfavorable outcome in human CDR is 
persistent pulmonary hypertension (PH)2~5. Indeed, follow up of surviving patients with 
CDH has revealed that the pulmonary perfusion scan does not improve although the 
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ventilation scan improves towards nearly normallcvel 7• 
Recently a developmental study of the lung vasculature showcd that in early gestation the 
pulmonary vasculature develops by a combination of central angiogenic sprouting and 
the formation of peripheral vasculogenic lakes, which progressively communicate with 
each other as the gestation advances8. A number of growth factors with a proven or 
potential role in vascular development and remodeling in health and disease conditions 
have been identified',IO, Vascular endothelial growth factor (VEGF), a potent angiogenic 
growth factor, has been repOlied to have a narrow target cell specificity to endothelial 
cells. Moreover, VEGF regulates vasculogenesis and postnatal vascular remodeling ll -J3 . 
VEGF binds to high affinity cell surface receptOl~, KDRlflk and flt, which are 
predominantly expressed in endothelial celislJ, Expression of VEGF is up refulated 
under a variety of pathophysiological conditions, including pulmonmy hypoxial2~1 , 
In order to investigate the pathogenesis of the underlying vascular abnol1nalities in CDR 
lungs, we investigated the cellular localization of VEGF in pulmonary autopsy specimens 
obtained from human CDH and age-matched control neonates. 
3,3 Materials aud Methods 
Tissue Specimells: 
Lung tissue specimens used in this study were obtained from our archival collection at 
the depmiment of Pathology. These specimens represent the available material from 
patients with CDR, who were treated in Sophia Children's Hospital, died and parents' 
consent for autopsy was obtained during thc period 1981 ~ 1997, Twenty~one CDR cases 
were identified. All cases were associated with lung hypoplasia, as evident from a 
lunglbody wcight ratio index ~ 0,012 15, The conh'ol group consisted of 7 age~matched 
neonates who died in the first 24 hours of extrauterine life because of neonatal asphyxia 
or placental insufficiency. These control cases did not have lung hypoplasia on 
histological screening, The CDR group had a gestational age vmying from 35 weeks to 
term, with a mean of38.4 weeks, while that of the control group was 35.1 weeks. Neither 
the CDR nor the control group was subjected to ECMO treahnent. We examined 
randomly either side of lung in this study, since on histological screening we did not find 
significant differences between the two lungs, as all cases represent the high-risk group of 
CDH. Lung tissue specimens \"ere fixed in formalin by immersion-fixation and 
embedded in paraffin for histopathological examination and inUllUllOhistochemistry. 
Jm mUll 0" ist oc" em is!ry: 
Paraffin sections (6 pm thickness) of the lung tissues were cut and mounted on 3-amino-
propyl~trioxysilane (Sigma, St Louis, MO, USA) coated glass slides. 
ImmunohistochemistlY was performed using a standard avidin-biotin complex (ABC) 
method as described earlier16,17. In brief, after deparaffinization in xylene and 
rehydration through graded alcohol, the slides were rinsed with water and phosphate 
buffered saline (PBS) and placed in a Sequeza Innnunostaining Workstation (Shandon 
Scientific Ltd, Astmoor, Runcol1l), Slides were preincubated for 15 minutes with normal 
goat senun to block non~specific binding, then incubated for 30 minutes at room 
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temperature with affinity-purified rabbit polyclonal antibodies in a dilution of I :200. The 
anti-VEGF antiserum used was raised against a 20 amino acid synthetic peptide 
corresponding to residues 1-20 of the amino terminus of human VEGF" (Santa Cmz 
Biotechnology, Inc., Santa Cmz, USA). 
The optimal dilution was identified by examining the intensity of staining obtained with a 
series of dilutions of the antisenll11 from 1 :50 to 1 :500. The dilution (1 :200) resulted ill 
specific and easily visible signals in paraffin sections of a capillaty hemangioma. The 
hemangioma sections selved as a positive conh·ol in the study. After washing with PBS, 
the test and control slides were incubated for 30 minutes with biotinylated secondary 
antibody (Multilink, 1 :75 dilution, Biogenex, San Ramon, MO, USA). After two washes 
in PBS, slides were incubated for 30 minutes with alkaline phosphatase conjugated 
streptavidin (Biogenex) in a dilution of I :50. Finally, the slides were rinsed with 0.2 M 
TRIS-HCL pH 8.0, Levamizole (Sigma) was used to block the endogenous alkalinc 
phosphatase activity, and stained for 30 minutes with 0.3% New Fuchsin/TRIS-HCL 
(Sigma) as color enhancement system. Negative controls were prepared by omission of 
the primary antisel1lll1. Slides were lightly counterstained with Mayer's hematoxylin for 
10 seconds. 
Immunolocalization of VEGF in endothelial cells as well as SMC was verified by 
staining these cells with specific markers. Endothelial cells were identified by CD31 
iml11unostaining!9. Staining was done by the ABC method, but using 0.025% 3,3-
diaminobenzidine (DAB) as chromogen. Slides were incubated for 20 minutes in 
methanol with 0.3% H,O, to block the endogenous peroxidase activity. Slides were 
incubated with the primary anti-human CD 31 monoclonal antibody in a dilution of 1:80 
(Dako COIporation, Glostmp, Denmark) at room temperature for 30 minutes and 
subsequently visualized after developing the color using 0.025% 3,3-diaminobenzidine 
(DAB) (Sigma). Employing DAB based color development method, consecutive tissue 
sections were stained with anti-human mouse monoclona) alpha-smooth muscle actin (a-
SMA) antibody (clone IA4: Biogenex) in a dilution of 1:200. 
SemiqtUllltitatil'e Au((lysis: 
Prior to screening sections were coded, so that the obselvers were unaware of the clinical 
details of the case under study. Expression of VEGF was analyzed semi quantitatively, 
using a semiquantitative visual scale, ranging fro111 OA: grade 0 = no staining, grade 1 = 
focal staining, grade 2 ~ diffhse faint, grade 3 ~ diffi.se moderate and grade 4 ~ difft.se 
strong staining, respectively'o. The entire slide of a tissue block, taken from the mid-lung 
area was investigated and scored at the same magnification by three independent 
obselvers. The average of the three scores used for subsequent analysis. Sections were 
graded from 0-4 for the localization of VEGF in the bronchial epithelium, endothelium 
and medial SMC in small (50-200 11m external diameter ED) and large (> 200 rllll ED) 
pulmonary m1eIies2!. This scoring method has previously been shown to allow the 
detection of differences in expression level as small as 1.5 times'o,,,. 
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Statistical AllItlysis: 
The VEGF staining score was calculated from the two groups, and the results were 
expressed as Median. Before ranking score values were rounded to the complete number. 
Statistical analysis was performed after ranking using one of the non- parametric tests 
either, Mann-Whitney test or Fisher's exact test according to what is appropriate to the 
compared groups. Significance of the results for probability value was accepted at P ,; 
0.05. 
3.4 Results 
Clillical alld Alltopsy Data: 
Thil1een of the 21 diaphragmatic hernias were left sided; the remaining 8 were light 
sided. All patients presented in the first six hours of life and were treated according to a 
standard protocol including conventional mechanical ventilation, cardiac ultrasound, and 
delayed surgelY!. Clinical evidence of light-to-Ieft shunting was obtained by preductal 
and postductal transcutaneous Orsaturation differences of > 10% in CDH cases23. 
Echocardiography documented the right to left shunt and pulmonmy hypertension. In 
three cases, associated major congenital anomalies were found: FaUoes tetralogy, 
tracheo-esophageal cleft, and trisomy 21, respectively (one each). Nineteen of the CDR 
cases died within 48 hours postnatally, five of these cases died in the first hour. In 3 
instances hyaline llleJnbrane disease was observed, whereas one patient developed 
pulmonary bleeding. All seven age-matched controls died in the first 24 hours after birth. 
Control cases were subjected to ventilatory therapy in settings similar to that of CDR 
cases, including inspiratOlY oxygen fraction of 1.0 for variable peliods of time up to 16 
hours postnatally. 
Localizatioll of VEGF: 
We detected VEGF in the bronchial epithelium and medial artelial SMC in control cases. 
Distinct VEGF inllllunostaining was identified in the bronchial epithelium and in the 
medial SMC of pulmonary artelies in tissue specimens from the CDR group, as verified 
with the inllllunolocalizaton of aSMA. VEGF immunoreactivity in bronchial epithelium 
and arterial medial SMC was more intense in the CDR cases than in the controls (Fig 1. 
A&B). 
See color pictures on page 124. 
In the CDH cases, VEGF staining in pulmonary vasculature was most intense in the 
medial SMC of small pulmon81Y arteries, with an ED under 200 ~1l1l. Righ VEGF 
expression levels were noticed also in the supemumerary arteries of CDR cases. 
Furthenl1ore, VEGF expression was detected in the endothelium of pulmonmy arteries 
only in CDR cases (Fig I.e). This endothelial staining was colocalized with consecutive 
sections stained with the endothelial cell marker, CD 31 (Fig 1.0). No VEGF 
imnmnopositivity was detected in the endothelium of control cases (Fig I.B). Weak 
VEGF expression was observed in the medial SMC of large pulmonary veins in CDR 
cases. 
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There were no differences in VEGF expression pattern between CDH cases that were 
atiificially ventilated up to 48 hours and the five cases that died in the first hour after 
birth despite maximal attempted resuscitation, even without receiving vigorous 
ventilatOlY suppOli, No VEGF expression was observed in the alierial medial SMC of 
pulmonary veins in the control group. 
Mean graded score values of thc semiquantitative analysis for the VEGF expression in 
CDH cases showed a maximal expression score value of 3.38 in the bronchial epithelial 
cclls, Endothelial and medial SMC of large pulmonary artcrics (ED> 200 ,Ull) depicted 
low staining values ofO.5 and 1.43, respectively, Statistical analysis ofVEGF expression 
scores in the two groups; CDH and controls, showed significantly higher levels (P s 
0,05) in the bronchial epithelium, medial SMC of large and small pulmonary arteries 
where P values were 0,001, 0,027, and 0,002, respectively, using the non-parametric 
Malm-Whitney U test as shown in Table I. 
Since no expression of VEGF in endothelium of pulmonary arteries in control cases was 
observed and the score was ahvays zero, Fisher's exact test was considered more 
appropriate for the comparison of endothelial staining scores24,,,, Significantly higher 
expression was observed in the endothelial cells of CDR cases using Fisher's exact test, 
with P values ofO,OI and < 0,001 for large and small pulmonary arteries, respectively, as 
compared to controls. 
Table I: Table oJraJ/kiJ/gdataJorA1mm-Whitlley U tesf 
Tissue examined N lUcan nmk SUIIl ofranks P value 
BI'OIIc!,;al epithelium 
CDR 21 17.38 365,0 0,001 * 
control 7 5,86 41.0 
Large arIel)' medial Slue 
CDR 21 16.45 345,0 0,027' 
control 7 8,64 60,5 
Small arIel)' medial Slue 
CDR 21 17,12 359,5 0,002* 
control 7 6,64 46,5 
Where: CDH = congenital diaphragmatic hernia, Sl\1C = smooth muscle cells, N = number am/ (*) 
indicates slalisfica/ d[tJerence at p :;0.05. 
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3.5 Discnssion 
We have found increased VEGF inununoreactivity in medial SMC and endothelium of 
pulmonmy arteries in CDR cases with pulmonary hypoplasia. The highest levels of 
expression in the pulmonary vasculature were observed in the medial SMC of arteties 
with a diameter of less than 200 ~Ull, and especially in the supernumerary arteries, which 
are known to play an important role in pulmonary blood pressure regulation and vascular 
resistance26 , 
Our results are in agreement with a previous experimental repOli confirming that, a 
source of VEGF is the arterial medial SMC". The increased VEGF expression detected 
in CDR cannot be due to artificial ventilation, since we did not find any difference in 
VEGF expression between the patients ventilated for short (up to 1 hour) or longer (up to 
48 hours) periods. In addition, no differences in the degree of VEGF expression were 
found in bronchial epithelium in the CDR group, regardless whether or not these lungs 
were exposed to high levels of inspiratOlY oxygen or volume trauma and shear forces 
related to variable pcriods of miificial ventilation, Since no significant differences were 
observed among either lung side in case of high-risk group of CDR regarding lung 
hypoplasia as descriped previollslj8,29, so we have examined randomly either side of 
lungs from CDR group and also lVe have found no differences. 
VEGF is recognized as an endothelial cell mitogen and angiogenic inducer with activity 
restricted to the vascular endothelial cells30,3!. VEGF is expressed in a variety of cells, 
and a paracrine mechanism of action has been suggested, whereby non-endothelial cells 
secrete VEGF, which modulates the vasculogenesis and angiogenesis in the adjacent 
vascular endothelium". Tins important angiogenic role of VEGF is evidenced from the 
fact that abnormal vessel development leading to death occurred in embryos lacking a 
single VEGF allele32, or followed the experimental inactivation of the VEGF gene bi 
replacing the coding sequence of exon-3 of the VEGF gene in emb!yonic stem eells' . 
We report endothelial reactivity for VEGF in the pulmonmy vasculature of human CDR 
hypoplastic lungs and not in the control cases, the latter being in accordance with a 
previous study report that VEGF is not expressed in the normal endothelium of the 
developing fetus". Rowever, it has been previously documented that in endothelial cells 
derived frommicrovessels, VEGF expression can be up regulated in vitro by hypoxia and 
adenosine34,35, 
There is much similarity between the struchnai changes in the pulmonmy vasculature in 
CDR hypoplastic lungs and that of another pediatric form of pulmonmy hypertension, 
namely, persistent pulmonmy hypeliension of neonates9,36, It is unclear whether similar 
growth factors and cytokines contribute to these vascular abnol'malities37 , FurthenllOl'e, it 
is of note that increased VEGF expression has been reported in lungs of patients with 
primary pulmonaty hypeltensio1l37, 
Our knowledge of vascular development in congenital diaphragmatic hernia and/or 
vascular remodeling following postnatal intelventions is far from complete, and it is too 
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early to speculate in detail about the pulmon31Y vascular abnormalities at the molecular 
level. No doubt, growth factors play an essential role in the pulmonmy and vascular 
development and mahlration38,39, The increased VEGF expression in small-diameter and 
supernumerary pulmonary arteries in CDH cases complicated by PH, may reflect an -
apparently unsuccessfhl- attempt of the developing fetus and the neonate to compensate 
for the stunted lung vessel growth andlor to stimulate the arterial angiogenesis of the 
pulmonary pressure-regulating mieties caused by a nlechanism which remains to be 
identified. 
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4.1 Abstract 
Pulmonary hypoplasia and persistent pulmonary hyperiension (PPH) are the principal 
causes of the ongoing mortality in congenital diaphragmatic hernia (CDH) presenting 
with rcspiratory insufficicncy within 6 hours after birih. Endothelin-l (ET-I) is an 
endothelial-derived vasoconstrictor, which could play an important role in modulating 
pulmonmy vascular tone in PPH. ET -1 exer1s its role in controlling vascular tone 
through two different subtype reccptors, endothclin-A receptor (ETA) which is 
rcsponsible for vasoconstriction and endothelin-B receptor (ETB) which is responsible 
for vasodilatation by induction of nitric oxide synthase. We examined the pulmonary 
expression ofET-I, ETA and ETB mRNAs in a rat model of CDR. CDH was induced 
in rats by administration of 100 mg of Nitrofen dissolved in olive oil on day 10 of 
gestation. Fetal lungs were collected following cesarean section on gestatiollal day 22 
(telln) and processed for NOlihern blot analysis and quantitative PCR. Significantly 
(p<0.05) enhanced levels of ET-I mRNA were observed in CDH rats as compared to 
control rats. In contrast to equal levels of ETB mRNA, a 2-4 fold increase in ETA 
mRNA levels were observed in CDH as compared to control rats. The uprcgulated 
expression of ET -1 and ETA receptor mRNA before bilih strongly suppOli the reason 
for pulmonmy vasoconstriction and altered pulmonmy vascular muscularization in 
CDR. Consequcntly in the clinical setting the use of endothelin receptor blockade for 
the treatment of PPH may be considered against the background of the unpredictable 
and variable response to inhaled nitric oxide in newboms with CDR. 
4.2 Introduction 
The high mOliality and morbidity in children with congenital diaphragmatic hernia 
(CDH) is largely determined by the severity of lung hypoplasia and by the therapy 
resistant persistcnt pulmonary hypertension (PPH).l Histopathologically, 
abnormalities in the pulmonmy vasculature in CDR are well documented.2,3 
HOlVcver, the question remains whether these morphological features are directly 
corrclated to the response of the pulmonary vasculature during the perinatal period. 
Clinical observasions show the reaction on a variety of vasoactive agents including 
inhaled nitric oxide (NO) to be highly unpredictable.4 
Recently two factors, NO and cndothelin-l (ET-I), have been put forward as essential 
vasoactive mediators in the perinatal pulmonary circuiatioll.5,6 Nitric oxide, produced 
in vascular endothelial cells by nitric oxide synthase (NOS) dUling the conversion ofL-
arginin to L-citndline, is a potent pulmonmy vasodilator, which increases the 
concentration of cOMP and results in smooth muscle cell relaxation.7 There are three 
types of NOS, the endothelial (eNOS), inducible (iN OS) and neuronal (uN OS). 
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Endothelial cells express eNOS and iNOS.8,9 In the nitrofen induced rat model of 
CDH, decreased eNOS protein and mRNA on 
gestational day 20 have been reported.l 0 Endothelin-l, a 2 I-amino acid polypeptide, 
also produced in endothelial cells, is a potent vasoconstrictor 1 1 and a mitogen for 
vascular smooth 
Fig. 1: Vascular balance hypothesis 
Vasodilatation 
NO ,j, 
Vasoconstriction 
Endothelin t 
muscle cells.l2 The effect of ET-l is directed through at least two distinct receptor 
subtypes; the ETA receptor localized on vascular smooth muscle cells mediates 
vasoconstriction, whereas the ETB present on the vascular endothelial cells mcdiates 
vasodilatation via the induction of NOS.S,!3 Although, high levels of circulating 
inullnunoreactive ET-I have been reported in human nconates with PPHl4 and 
CDH,IS the pulmonary expression and the exact mechanisms how ET-I and its 
receptors interact to regulate pulmonaty vascular tone in CDH are not fully understood 
(Fig. 1). 
We hypothesized that in CDH altered pulmonary vascular reactivity might be related to 
differential expression of ET-l and its receptors. Therefore, the present study was 
undeliaken to examine the pulmonaty expression of ET -1 , ETA and ETB receptor 
mRNAs in a rat model of CDH and to compare the expression pattern with age 
matched controls. 
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4.3 Materials and Methods 
Experimelltal protocol 
Adult female Sprague-Dawley rats were mated overnight. Observation of positive 
smears was considered as a proof of pregnancy (day 0 of pregnancy). To induce CDR, 
100 mg of 2,4-dichloro-phenyl-p-nitrophenylether (nitrofen) dissolved in 11111 olive oil 
was given on day 10 of gestation as described before,16 In control animals, I 11110f' 
olive oil was given without nitro fen. At tenn (gestational age 22 days), the mothers 
were anesthetized by inhalation of ether and cesarean section was performed. The 
lungs from CDR and control fetuses were removed and snap frozen in liquid nitrogen 
and stored at -BO°C until analyzed. 
Extmctioll of RNA alld Nortilel'lI blot allalysis 
Total cellular RNA was extracted from 100 mg of frozen lung tissue by the method of 
Chomzynski and Sacchi. 17 Ten g of total RNA was denatured and size fractionated 
on 1% agarose gel containing 2.2M fannaldehyde, subsequently transferred to Rybond-
N membrane (Amersham Nederland B.V., 's-Hertogenbosch). Filters were hybridized 
with a 32p-labeled cDNA probe specific for the rat ET-IIB and washed under stringent 
condition and exposed to Kodak x-omat® films. Hybridization conditions were calTied 
out as described before,19 For reference purpose, a glyceraldehyde-3-phosphate 
dehydregenase (GAPDR) cDNA probe was used to rehybridize membranes. After 
autoradiography and densitometric measurement of signals, the optimal density (OD) 
of the ET-I signal was divided by OD of the corresponding GAPDH signal and relative 
mRNA levels were calculated (mean ± S.E.). Expression was statistically analyzed 
using student's t-test and significance was accepted at p<O.OS. 
QII(lIItitatil'e RT-PCR 
Using specific oligonucleotide primers, ETA receptor, ETB receptor20 and cyclophilin 
cDNA fragments were selectively amplified in a competitive reverse transcriptase 
polymerase chain reaction (RT-PCR). Synthesis of eDNA mimic templates for 
competitive RT-PCR was carried out using deletion primer, providing amplified cDNA 
with priming sites identical to those of the gene of interest, but with a shorter 
intervening sequence to allow for separation by gel electrophoresis. Bands were 
quantitated on the basis of 32p-dCTP incorporation. Relative intensities of amplified 
product and mimic Were plotted on a semi-log scale to obtain the tlequivalence point" -
the point at which the concentration of the cDNA of interest was equal to the known 
concentration of mimic cDNA template. Results for CDH lungs are expressed as 
percent of control after normalization to cyclophilinlevels. 
47 
Chapter 4 Pulmonary Vascular Balance in CDR 
4.4 Results 
Nitrofen induced CDR in rats is a well established model in our laboratmy. In this 
study, more than 80 % of fetuses developed left sided CDR. Both left and right lungs 
from only left sided CDR fetuses were examined for the expression of ET-I and its 
receptor at mRNA level. Significantly (p<0.05) enhanced levels ofET-1 mRNA were 
observed in CDR rat lungs as compared to controls (Figure 2). No significant 
differences in the expression of ET-I mRNA between right and left lung (the most 
hypoplastic) in CDR rats were observed (fig 2A and B). A 3.0±O.9 fold increase in 
ETA mRNA was observed in CDR as compared to controls (Figure 3, 4), whereas ETB 
mRNA levels remained unchangcd in both CDR and control rats (Figurc 4, 5). 
4.5 Discussion 
In the present study, we found enhanced levels of ET -I and ETA receptor mRNAs in 
CDR rat lungs on gestational day 22, indicating for a potential role ofET-1 and ETA 
receptor system in regulating the pulmonmy vascular tone. Based on their specific 
biological properties, recent interest has focused on endothelin and NO pathways in the 
fetal and perinatal pulmonmy circulation. NO produced in vascular endothelial cells by 
NOS is a potent pulmonaty vasodilator.7 ET-I increases pulmonaty vascular 
resistance through its interaction with the ETA receptor which is localized on vascular 
smooth muscle cells,21 whereas ET-I induces NOS using thc ETB receptor which is 
present on the vascular endothelial cells.22 It has also been reported that 
administration of a selective ETA receptor antagonist (BQ 123) decreases pulmonmy 
vascular resistance in fetal lambs.23 
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Enhanced mRNA levels of ET·1 and ET·A for the 
regulation of pulmonary vascular tone in CDH 
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FUlihermore, ETB receptor stimulation by sarafotoxin S6c results in vasodilatation 
through endothelial cell NO release.5 Moreover, application ofa nonselective ETA and 
ETB receptor antagonist (Bosentan@) has shown to attenuate the development of 
hypoxic pulmonary hypeliension in rats. 24 In experimental rat and lamb models of 
CDH, differential expression pattenlS of NOS mRNA and protein have been reported 
so far. 10,25,26 On the other hand, responses to inhaled NO are divergent and 
unpredictable in human cases of CDH.4 Our findings suggest that in addition to the 
altered NO pathway, the ET-I - ETA receptor system is upregulated which may 
contribute to altered pulmonary vascular reactivity in CDH (Fig. 6). In a recent study 
of human cases of CDH, we obselved high levels of 6-keto-PGFI , a vasodilatory 
eicosanoid, in branchoalveolar lavage fluid in CDH patients with PPH27, as an attempt 
of the body to overcome the vasoconstrictive status of the pulmonary vasculature. 
Furthennore, ET-l is a mitogen for vascular smooth muscle cells.l 2 Enhanced 
expression of ET-I may also be attributed to the abnormal pulmonary arterial 
muscularization in CDR. In this study, there were no significant differences in the 
expression ofET-lmRNA between left and right lungs ofCDH rats. In human cases 
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of CDH, it has been repOlted that the pulmon31Y vascular abnormalities are bilateral, 
but the ipsilateral side is more severely changed as compared to the contralateral 
side.28 
The present study was restricted to the observation at mRNA level. FUlther elucidation 
of protein expression and tissue localization are warranted in our model. Recently new 
trials of ETA blockade and ETB stimulation have been initiated in the CDH lamb 
model as an intervention for pulmonaty vasoconstriction in CDH with promising 
results29 . Our findings may support the pharmacological modulation of pulmon31Y 
vascular tone by the ETA blockade as an alternative treatment modality for CDR 
associated with PPH. 
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4.6 Figul'es: 
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Figul'e 2: Norlhem bioI allalysis of ET-J expression ill cOlllrol alld CDH IlIlIgS. 
Panel A: Filters were hybridized with ET-l cDNA probe (upper panel) and GAPDH 
(lower panel) for reference purposes. Autoradiography shows enhanced expression of 
ET-I mRNA in CDH lungs. Panel B: Bar graph shows relative levels ofET-lmRNA. 
#,*: significantly different from respective control lungs (both RL and LL) (p<O.05). 
RL=right lung, LL~left lung, C~control rats. 
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Figure 3: Quantitative RlcpCR of ETA receptor expression in contl'ol and CDH 
IUI/gs. 
Autoradiography of ETA receptor is sholVn after electrophoresis 011 an agarose gel 
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Figure 4: Qllallti/alive RT-PCR of ETA alld ETB receptor expressioll ill cOlltrol alld 
CDH rat/lll1gs. 
Bar graph shows the values of ETA receptor mRNA expression (left panel) as percent 
of control. About 3 fold increase in ETA mRNA was observed in CDH rat lungs as 
compared to controls. Right hand panel shows ETB receptor mRNA expression as 
percent of control. There was no significant change in ETB mRNA expression between 
CDB and controlillngs. 
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Figure 5: Qualltitative RT-PCR of ETB receptor expressioll ill cOlltrol alld CDH rat 
IUllgs. 
Ethidiulll bromide staining of the agarose gel for the ETB receptor is shown. 
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5.1 Abstract 
Artificial ventilation in human cases of congenital diaphragmatic hernia (CDH) may 
result in a progressive damage of the lung due to shear forces, activation of cytokines 
and oxygen toxicity. Partial liquid ventilation (PLV) might be an altel11ative ventilatory 
mode to prevent lung damage. However, it is not known whether, as a result of 
conventional ventilation (CV) or PLY in CDH cases, the stress imposed on lungs could 
result in the induction of stress genes as a sign of molecular adaptation. Using a rat 
model of CDH, we studied the luug mechanics and asscssed the pulmonary stress 
imposed by two (CV and PL V) modes of ventilation by examining the expression 
pattern of heat shock proteins (HSPs), HSP-70 and HSP-27. To induce CDH, 100 mg 
of Nitrofen in olive oil was given to Sprague-Dawley female rats on day 10 of 
gestation while control animals received only thc vehicle. Foetuses obtained by 
caesarean section on gestational day 22 (term) were either conventionally ventilated 
(freq. 40; PIP 25-17; PEEP 3; Fi02 1.0) or given perfluorocarbon (l5mllkg body 
wcight) keeping the oxygen saturation abovc 96% in both groups. After 4 hours of 
ventilation, lung tissues were collected and processed for the measurement of lung 
mechanics, Northel11 blot analysis and (immuno )histochemistry. Following PL V, 
increased total lung volume in both control and CDH and improvement in opening 
pressure only in case of CDH group was observed as compared to respective CV 
groups. HSP-70 mRNA levels were enhanced in CV as compared to PLY rats in both 
control and CDH groups (p<0.05). Howcvcr, the expression of HSP-27 mRNA was 
elevated in CV as compared to PLY rats in control group. Immunohistochemical 
localisation of both HSP-70 and 27 showed distinct staining in ainvay epithelial cells 
and vascular smooth muscle cells in CV and PLY lungs in both control and CDH 
groups. Though, the pattern of expression of HSP-70 and 27 was similar, 
semiquantitative analysis using an arbitrary staining scale of OA showed increased 
expression in rats with CV as compared to PLY. Our results clearly demonstrate for the 
existence of endogenous defence mechanisms in hypoplastic CDH lungs and PLY 
appears to be less strenuous as compared to CV. 
5.2 Introduction 
The high modality and morbidity rate in patients with congenital diaphragmatic hernia 
(CDH) is largely determined by the severity of lung hypoplasia and persistent 
pulmonary hypertension (PPH),l In survivors beyond the immediate neonatal period an 
increased incidence of bronchopulmonary dysplasia (BPD) has been reported in CDH 
because artificial ventilation with high peak inspiratory pressures and a high inspiratory 
oxygen fraction are often required in the neonatal period),3 Moreover, the antioxidant 
enzyme system in the lungs of CDH cases is known to be deficient.4 Ventilation with 
perfluorocarbon has been shown to improve gas exchange and lung function in clinical 
and experimental conditions including CDH.5-8 Pal1ialliquid ventilation (PLV) is a 
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modified technique of ventilation with perfluorocarbon, in which the lung is filled till 
functional residual capacity with perfluorocarbon and tidal volume vcntilation is 
performed by additional conventional ventilation,9 Prcvious studies suggested that 
PLY might be the solution to prevent ventilation induced chronic lung damage lO and 
enhancing survival rate in patients with CDH,l1 However, it is not known whether, as 
a result of PLY in CDH, the stress imposed on lungs induces stress genes as a sign of 
molecular adaptation or alters in comparison with a regimen of conventional at1ificial 
ventilation. 
-HSP-27 
Figure 1: Schematic diagram showing the intra-cellular'l'ole ofHSPs 
Heat shock proteins (HSPs) are a group of highly conserved proteins that can be 
induced by heat shock and in a variety of pathophysiological conditions including 
hypoxia, oxidative and metabolic stress)2-15 The HSP-70 family of proteins bind to 
ATP and are of help in post-translational import of proteins into the cndoplasmic 
reticulum and mitochondria (Fig, 1).1 5,[6 HSP-70 and HSP-90 are known as 
regulators of glucocorticoid receptor function)7, [8 The small heat shock protein 
HSP-27 is expressed in developing organs as well as in cancer cells, migrates to the 
62 
Chapter 5 Pulmonary Stress Response in CDH Rats 
nucleus upon stress, acts as a molecular chaperone, and plays an important role in 
signal transduction 19 Moreover, it has been reported that RSPs participatc m 
embryonic and foetal development. Small RSPs are considered to be involved in 
organisation of the intracellular matrix and the preservation of cell structure.20 
Thc aim of the prescnt study was to evaluate how PL V influences the lung mechanics 
and to cxamine the mRNA expression and tissue localisation ofRSP-70 and RSP-27 as 
strcss markers in CDR and control rat lungs in a comparative study of CV and PLY. 
5.3 Materials and Methods 
Study desigu 
Adult female Sprague-Dawlcy rats (Harlan Olac, England), average body weight 250 
grams, rats were mated overnight. Obselvation of positive smears was considered as 
proof of pregnancy (day 0 of prcgnancy). To induce CDR, 100 mg of 2,4-dichloro-
phenyl-p-nitrophenylether (Nitrofen) dissolved in I ml of olive oil was given on day 10 
of gestation as described before4 In control animals at 10 days of gcstation, the same 
dose of olive oil was given without Nitrofen. Watcr and food were supplied ad libitum 
during the whole period of thc experimcnt. On gestational day 22, the fetuses were 
delivered by caesarean scction and they were immediately anaesthetised and intubated, 
followed by artificial vcntilation.4 To start with, thc ventilatory settings were as 
follows, PIP (peak inspiratory pressure) ~ 25 cmR20, PEEP (positive end cxpiratory 
pressure) ~ 3 cmR20, frequency ~ 40 breaths/minutes, Fi02 (fraction of inspiratory 
oxygen) ~ 1.0. After 30 minutes of ventilation, animals were randomised in a 2: I order 
to receive eithcr 15 ml / kg of per fluorocarbon (n~81) or continuation of CV (n~42). 
Five minutes after perfluorocarbon administration, PIP was reduced to 17 cmH20 and 
animals were ventilated for 4 hours. Oxygen saturation was kept over 96% in all 
animals as measured with a pulse oximetry probe (Nellcor, USA) attached to the foetal 
head to prevent interfcrence with respiratory movemcnts. Thc perfluorocarbon 
compound (RM-I 0 I) used in our experiments had the following characteristics: density 
1.77 g/ml; vapor pressure 64 mmRg at 37°C; surface tension 15 dyne/cm; 02 solubility 
52 mliIOOml; C02 solubility 160 mlilOOml. Following 4 hours of ventilation, foetuses 
were removed from the ventilator and their pressure volume Cmves were assessed. 
Lungs were dissccted out and processed for thc NOllhern blot analysis, routine 
histology and immunohistochemical examination. 
Measuremeuts Of/illIg mec/ulllics 
Evaluating pressure-volume curves as described earlier lung mcchanics was 
asscssed21 . A time on thc ventilator was chosen in all our experiments because 
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significant metabolic derangements occur after 6 hr of ventilation this neonatal rat 
modelofCDH. Four hrs of ventilation makes our data comparable with fonner studies 
from our laboratory22 using the same approach. After 4 hours of atiificial ventilation, 
at random the trachea of rat pups was exposed and cannulated with a 24 G catheter 
connected with a water manometer and a syringe. Subsequently pups were submerged 
in a saline-filled bath on an elcctronic balance. Air from the syringe gradually inflated 
the rat lungs to increase airway pressure in increments of 5 cm H20 to a maximum 
pressure of 30 cm H20 by intervals of 30 seconds for equilibration, following deflation 
of the lungs in 5cm H20 decrements. Changes in lung volume were recognised as a 
change in weight of the system, Lung volumes at distinct airway pressure were 
recorded after calibrating the balance and water manOlnetel' connected with the animal 
submerged and serial pressure-volume curves were made, At least 5-7 curves for the 
different conditions were made. 
Isolalioll ojlolal celllliar RNA al/{I Norlhem bioi allalysis 
For Northern blot analysis, both CDI-] and control foetuses were sacrificed immediately 
after caesarean section and lungs were removed from the thoracic cavity, snap frozen in 
liquid nitrogen and stored at _SOoC until analysed. Total cellular RNA was extracted 
from 100 mg of frozen lung tissue by using a guanidinium thiocyanate-phenol-
chloroform method.23 ,24 The RNA concentration was measured by 
spectrophotometry. For Northern hybridisation, 10 fig of total RNA was denatured at 
65°C and electrophoresed on 1% agarose gel containing 2.2M formaldehyde. Gels 
were photographed and RNA was transferred to hybond-N membrane (Amersham 
Nederland B.V., Den Bosch). Thereafter, filters were air-dried and UV cross-linked in 
a gene linker (Bio-Rad Laboratories B.V., The Netherlands). Blots were hybridised at 
42°C in a buffer containing 50% deionized formam ide, 1.0M sodium chloride, 1% 
sodium dodecyl sulfate (SDS), 0.2% polyvinyl pyrrolidone, 0.2% ficoll, 0.2% bovine 
senlln albumin, 50mM Tris-HCI (pH 7.5), 0.1% sodium pyrophosphate, 10% dextran 
sulfate and denatured salmon sperm DNA (100 flg/ml). cDNA probes used for 
hybridisation were 2.1 kb DNA fragments encoding human HSP-70 and 0.9 kb DNA 
fragments encoding human HSP-27. cDNA inserts were labelled employing a 
multiprime labelling system (Amersham Nederland B.V., Den Bosch), to a specific 
activity of 109 cpm/flg DNA using [32Pl-dCTP (3000 Cilmmol, Amersham Nederland 
BV. Den Bosch). After overnight hybridisation, filters were washed at room 
temperature for 5 min in 2x SSC (1x SSC ~ 0.15M NaCI, 0.015M sodium citrate) 
eOlltaining 0.1% SDS and at 42°C in O.lx SSC containing 0.1% SDS for 20 min. 
Subsequently, filters were wrapped in a household plastic wrap and exposed to Kodak 
X-OMAT AR films (Kodak Nederland B.V., Odijk) at -SOoC for 24 hours. A 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe (1.2 kb Pst! 
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fragment of human eDNA, procured from A TCC, USA) was used to rehybridize 
membranes for reference purposes. After autoradiography and densitometric 
measurement of signals, the optical density (OD) of the HSP signal was divided by OD 
of the corresponding GAPDH signal and relative mRNA levels were calculated. 
Histology 
For histological examination, lungs were fixed in two different ways. A 24G needle 
was inserted into the trachea and the lungs were fixed by injection of Davidson solution 
(40 vol % ethanol; 5 vol % acetic acid; 10 vol % formaldehyde; 45 vol % 0.9M NaCI; 
pH7.3) into the trachea at a prcssure of 20 cmH20 for at least 4 to 6 hours as 
previously described by Buri et. a1.25 . Consequently the lungs were expanded. Other 
lungs were removed together with the heart and immersed directly in Davidson 
solution in order to assess the acration paltem. Additionally both CDH and control 
fetuses were sacrificed immediately after caesarean section and processed further for 
fixation and referred to as non-ventilated groups. After fixation, the lungs were 
embedded in paraffin. Six pm thick sections were cut and mounted on poly-L-Iysin 
coated microscope slides and processed for the routine Hematoxylin-Eosin staining to 
assess the lung histology 
IlIllllllllofl ;stocflelll ;stJ'J' 
Six gm thick sections from lungs following inflation fixation were processed for 
immunohistochemistry using a standard avidin-biotin complex (ABC) method as 
described earlier26. In brief, after deparaffinization in xylene and re-hydration through 
graded alcohol, the slides for HSP-70 were incubated for 20 minutes in methanol with 
0.3% H20, to block endogenous peroxidase, then boiled in a citrate buffer for 15 
minutes, rinsed with phosphate buffered saline (PBS) and placed in Sequenza 
Immunostaining Workstation (Shandon Scientific Ltd, Astmoor, Runcorn). Non-
specific binding sites were blocked by incubation in 10% normal goat serum at room 
temperature for 20 min. Slides were incubated at room temperature for one hI' with 
mouse monoclonal antibody to HSP-27 (dilution 1:750) or with mouse monoclonal 
antibody to HSP-70 (dilution 1:25), both procured from Neo Markers, Fremont, USA. 
After rinsing with PBS, the slides were incubated for 30 minutes with biotinylated 
secondary antibody (Multilink, I :75 dilution, Biogenex, San Ramon, MO, USA). Slides 
were rinsed again, incubated for 30 minutes with peroxidase conjugated strcptavidin for 
HSP-70 and with alkaline phosphatase conjugated streplavidin for HSP-27, using a 
dilution of 1 :50 for both (Biogenex). In case of HSP-70 slides were colored using 
0.025% of 3,3-diaminobenzidine (Sigma, St Louis, MO, USA) in 0.01 mol/L PBS, 
containing 0.03% H,O". Slides for HSP-27 staining were rinsed with 0.2 mol/L TRIS-
HCL pH 8.0, incubated with levamizole in order to block the endogenous alkaline 
phosphatase activity, then stained with 0.3% New FuchsinrrRIS-HCL (Sigma) and 
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briefly counterstained \vith Mayer's hematoxylin. Positive controls consisted of human 
breast carcinoma tissue specimens. The optimal dilutions for both HSP antibodies were 
identified by examining the intensity of staining obtained with a series of dilutions 
ranging from I: I 0 to I: I 000. The dilutions chosen for this study resulted in specific and 
easily visible signals in paraffin sections of breast carC1lloma. Negative controls 
consisted of omission of the primary antibody. 
Semi-qllalltitative {/Ill/lysis of HSPs localisatioll 
Expression of HSP-27 and HSP-70 was analyzed semi-quantitatively, using an arbitrmy 
visual scale ranging from 0 to 4: grade 0 represents no staining, grade I represents focal 
staining, grades 2,3 and 4 represent diffuse weak, moderate and strong staining, 
respectively. This method has been widely used in earlier studies26,27. Prior to 
screening by three independent observers, sections were coded so that all three observers 
were unaware of the experimental groups. Sections were graded from 0-4 for the 
intensity of inullunostaining signal for HSPs in the bronchial epithelium, as weB as in the 
endothelium and medial smooth muscle cells (SMC) ofpulmonmy arteries. 
Statistical (Illalysis 
Data from pressure-volume CUlves and densitometric analysis of Northern blots were 
presented as mean ± SEM and analyzed by using student's t-test. Statistical 
significance was accepted at p-values less than 0.05. Semi-quantitative analysis of 
HSPs expression at protein level was performed using visual scoring method. 
Immunostaining of HSPs scoring values may not be normally distributed and hence the 
data in addition to the student's "f' test was statistically tested using a non-parametric 
Mann-Whitney test where applicable. In few cases as the values were ranging from 0-
3 with several values at 0, we have opted for Fisher's exact test instead of Mann-
Whitney. 
5.4 Results 
Lllng mechanics 
The pressure-volume curves showed a marked increase in the lung volume at each 
pressure point (airway pressure between 0-30 emH20 with increments of 5 emH20) in 
control rats who underwent CV as compared to those who were subjected to PL V (Fig. 
2A). The mean lung volume in control rats at 30 emH20 increased from 373±23.1 frl 
after CV to 416±41.0 ftl following PLY. As shown in figure 2B, a beneficial effect of 
perfluorocarbon on opening pressure in CDH rats was also observed (Fig. 2B). 
Although, CDH rats who received CV did not show any inflation at 10 cmH20, 
however those CDH rats who underwent PLY demonstrated a mean lung volume of 
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56±25.0 f" at the same pressure. Mean lung volume in COH rats at pressure 30 
cmH20 also increased significantly from 173±30.5 fll in CY group as compared to 
242±21.7 III in PLYgroup (Fig. 2B). 
Histological examiltatiolts 
In CV lungs, an alveolar aeration-pattern was observed in control rats, whereas a 
centro·acinar aeration pattern could be seen in COH rats (Fig. 3A, B). Following PLY, 
a marked change towards improved aeration pattenl was observed in both control and 
CDH rat lungs (Fig. 3C and D). No inflammatory cellular infiltration was observed in 
either group. 
See colour pictures (Fig. 3) on page 126. 
Effects of artijicial velltilatioll 011 tlte expressioll of HSP-70 alld HSP-27 IIIRNAs 
By Northern blot analysis, we detected two mRNA species of 3.5 and 2.7 kb encoding 
HSP· 70 in the lungs derived from both CDH and control rats (Fig. 4A). Baseline 
expression of HSP· 70 mRNAs at birth showed no significant differences between CDH 
and control rats. Densitometric analysis of HSP· 70 mRNAs showed significantly 
enhanced (p< 0.05) levels ofHSP·70 mRNAs in rats followed CY as compared to PLY 
in both the control and CDH groups (Fig. 4B). 
A single mRNA species of 0.9 kb hybridising to the HSP-27 probe was detected in the 
lungs obtained from each experimental group (Fig. 5A). Like HSP· 70 expression 
baseline levels of HSP·27 mRNAs at birth showed no significant differences between 
CDH and control rats. The expression of HSP-27 mRNA was enhanced significantly in 
CY as compared to non· ventilated (NY) and PLY lungs in control rats (Fig. 5B). 
However, there were no differences in the expression pattern of HSP-27 mRNA among 
NY, CY and PLY in case ofCDH rats. 
Effects of artijiciall'elltilatioll Oil tlte localisatioll of HSP-70 al/{I HSP-27 
Immunohistochemical localisation of HSP· 70 and HSP·27 revealed that these stress 
proteins were expressed in conducting and terminal ahway epithelial cells in the lungs 
of both control and CDH rats, irrespective of the mode of ventilation (Fig. 6, 7). Pattern 
of expression for HSP· 70 and HSP·27 immunoreactivity was also observed in vascular 
smooth muscle cells in all above groups. Intense staining for HSP·27 in the large 
pulmonary arteries of both control as well as COH groups was observed (Fig. 6A and 
B). The effects of mode of ventilation on the expression ofHSP-27 became apparent at 
the level of large pulmonary arteries where the expression was less in case of PL V 
treated control rats (Fig. 6A and C). Endothelial staining the large pulmonary arteries 
of control rats kept on PLY was also observed (Fig. 7C). 
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Semiwquantitative analysis using an arbitrary visual scale ranging from 0 to 4 revealed 
that the cellular distribution patterns for both the HSPs were almost similar in the lungs 
derived from CDH rats irrespective of the ventilatory conditions (see also Fig. 6,7). 
However, pulmonary expression of HSP-27 was significantly decreased in control rats 
kept on pattial liquid ventilation (staining score: 2.1 ± 0.16) as compared to 
conventionally ventilated control rats (staining score: 3.2 ± 0.24) (see Fig. 6A and C). 
See colour pictures (Fig. 6 alld 7) on page 128·131. 
5.5 Discussion 
In the present study, we demonstrated the increase in total lung volume in both control 
alld CDH lungs and improvement of opening pressure in CDH lungs in PLY as 
compared to CV, indicating improved compliance by PLY. Histological examination 
revealed that the aeration pattern shifted from a centrowacinar to an alveolar pattern. 
Significantly enhanced expression of HSP-70 and HSp·27 InRNAs was observed in 
CV as compared to PLY in control group. In CDH rats the levels of HSP-70 mRNA 
were higher in the CV as compared to PLY, whereas, HSP-27 mRNA levels remained 
unaltered in CV as compared to PL V rats. Inll11unohistochemically, both HSP-27 and 
HSP-70 protein levels were elevated in CV rats as compared to PL V rats both in CDH 
as well as in control groups. 
HSPs can be stimulated by a variety of pathophysiological stresses. 12- 15 In our 
experiment, the inspiratory oxygen fraction of the ventilator was 1.0 and all pups had 
transcutaneous saturation values of 96% or more during the 4 hours of ventilation. In 
control rats the expressions of HSP-70 and HSP-27 mRNA were significantly 
enhanccd in CV group as compared to PLY. While the initial protection of the lungs 
from oxygen free radicals during exposure to hyperoxia and barotrauma in neonates is 
considered to be provided by non-enzymatic antioxidants28, another study from our 
group revealed that antioxidant enzyme (AOE) activities increased gradually in normal 
rat pups during 5 hours of ariificial ventilation but werc decreased in CDH rats.29 Our 
current data suggest that PLY reduces the stress of artificial ventilation with a high 
concentration of oxygen as indicated by decreased opening pressure, and increased 
total lung volume. 
It has been repOlied that HSPs can playa role in organ development in the embryonic 
and fetal period. Our results showed that the same levels of HSP-70 and HSP-27 
mRNA and their proteins were present in airway epithelial cells and vascular smooth 
muscle cells in both control and CDH rat lungs. In addition, alterations of HSP-70 and 
HSP-27 mRNA expressions after 4 hours of ventilation were observed in CDH lungs as 
well as control lungs on day 22 of gestation, indicating that lungs in CDH rats respond 
to ventilatory stress by induction of HSPs. In other words the hypoplastic lung is not 
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different from the control with regards to the baseline ability to react to hypoxic insults. 
These data are comparable with the responsc of AOE activity in this model system as 
shown previously.22 It is possible that 4 hours of ventilation is too short to observe 
alterations at protein levcl as invcstigated by immunohistochemistry. Although rat 
lung development is transitional from the saccular phase to the alveolar phase on day 
22 of gestation29, previous studies from our group showed that fetal rat lungs are 
retarded morphologically comparable with day 20 of gestation in hypoplastic lungs in 
Nitrofen induced CDH rats.30 On the other hand, significantly lower expression of 
surfactant protein (SP)-A mRNAs was obscrved in CDH rat lungs on gestational day 
20, but no difference was seen betwecn CDH and control lungs at birth. Different 
cxpression pattem of SP-B and SP-C were also observed between gestational day 15 to 
18 in CDH rat lungs, whereas the levels of these mRNA were similar betwecn CDH 
and control lungs on gestational day 22.3 1 Thus, the relationship between 
morphological and functional development in CDH rat lungs is not completely 
clarified. Moreover, it is not known when HSPs genes are expressed for the first time 
and how HSPs affect the lung development and endogenous cellular defence 
mechanisms in CDH. 
PL V has been shown to improve gas exchange and lung mechanics in animal models of 
CDH and in premature infants.5-8 Recently the first positivc results have become 
available using PL V in combination with ECMO in 7 human cases of CDH with 
survival in 5 of them (Jay Wilson, personal communication). Moreover, PLY 
combined with inhalation of nitric oxide reduces pulmonary hypeliension and enhances 
oxygenation in CDH.6,32 Aggressive ventilatory support is often required to maintain 
adequate blood gases in patients with hypoplastic lungs in CDH. The enhanced 
expression of HSPs mRNA in CV as compared to PL V in control rats indicates that 
PL V leads to a less amount of stress in ventilated lungs. We observed a different 
expression pattern of HSP-27 mRNA in CDH rats. As described above, f\mctional 
development of lungs in CDH is still partly understood. HSP-27 is known to be a 
major target of phosphorylation in response to stimuli and is rapidly phosphorylated by 
several oxidants and oxyradical generating agents including cytokines33 , and then 
synthesis is enhanced. Although the duration of artificial ventilation was 4 hours and 
no cellular infiltration was observed, a differential expression pattem of AOE activity 
during artificial ventilation were observed previously in the same rat model of CDH.22 
This might result in a differential expression pattern of HSP-27 mRNA in CDH rats. 
Whethcr these different endogenous stress responses following atiifieial ventilation 
might contribute to the high incidence of chronic lung disease following atiificial 
ventilation in high risk CDH can only be elucidatcd by studying human specimen 
following different vcntilation strategies. We have recently finished a study on 24 
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cases of human CDH where we found a positive effect of extracorporeal membrane 
oxygenation (ECMO) treatment on pulmonary HSPs expression (Shehata et a1. 
unpublished). The problem remains that in humans only autopsy cases are available 
representing a subset of patients with the limited diagnosis. 
In conclusion, we showed the improvement of lung mechanics following PLY and 
enhanced expression of HSPs mRNAs in CV as compared to PL V in control rats, 
suggesting that PLY leads to less stress during artificial ventilation of hypoplastic lungs 
although a different expression pattern of HSP-27 was observed in CDH. Our study 
strongly supports the idea that PLY alone, or in combination with ECMO, as an 
additional therapy to open up the hypoplastic lungs and might be of great benefit to 
diminish ongoing stress of the lungs in the clinical situation. 
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Figure 2: Pressure-volume curves iu conh'ol and CDH rats after CY and 
PLY. 
(A) Control rats subjected to CY for 4 hours (solid line) or PLY (broken line). A 
marked increase of the lung volume at each pressure was observed in rats given 
PLY as compared to CV. 
(B) Pressure-volume curves in CDH rats after 4 hours of CV (solid line) or PLY 
(broken line). An increase of the lung volume was also found in CDH rats 
subjected to PLY. 
#: significantly different from CV at corresponding pressure point (p<O.05); 
*: significantly different from CV at corresponding pressure point (p<O.Ol) 
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Figure 4: Northern Blot analysis of HSP-70 mRNA expression in control and 
CDH rats subjected to CV and PLY. 
10 f'g of total RNA extracted from lugs of control as well as CDH rats was denatured 
and electrophoresed on 1% agarose gel and blotted on a nylon membrane as described 
in "Materials and Methods" section. Filters were hybridized with HSP-70 cDNA probe 
(Panel A; upper part) and with GAPDH (Panel A; lower part) for the reference and 
RNA loading correction purposes. Autoradiography shows two mRNA species of 3.5 
and 2.7 kb encoding HSP-70 in the lungs derived from both CDH and control rats. 
Panel B: Bar diagram shows relative levels of HSP-70 mRNAs in control and CDH 
lungs subjected to CV or PLY. Note the decreased mRNA levels of HSP-70 in PLY 
treated rats. 
#,* depicts significantly different from respective lungs subjected to PLY (p<O.05). 
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Figure 5: Northel'll Blot allalysis of HSP-27 mRNA expressioll in cOlltrol alld 
CDH rats subjected to CY and PLY. 
10 j.lg of total RNA was denatured and electrophoresed on 1% agarose gel and blotted 
on a nylon membrane as described in 41Materials and Methods" section. Filters were 
hybridized with HSP-27 cDNA probe (Panel A; upper part) and with GAPDH (Panel 
A; lower part) for the reference and RNA loading correction purposes, Autoradiography 
shows a single mRNA species of 0,9 kb encoding HSP-27 in the lungs derived from 
both CDH and control rats. Panel B: Bar diagram shows relative levels of HSP-27 
mRNA in control and CDH lungs subjected to CY 01' PLY, Note the decreased mRNA 
levels of HSP-27 only in control rats subjected to PLY, 
#,. depicts significantly different from respective lungs subjected to PLY (p<0.05). 
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6. t Introduction 
In new-borns with respiratory insufficicncy, artificial ventilation with high peak 
respiratOlY pressures, resulting in volutrauma of the pulmonary parenchyma, combined 
with high respiratOlY oxygen, levels may lead to progressive lung damage ref. [1-12]. 
Several repmts have documented the role of a number of mediators in different tissue 
components as etiological fhctors for the development of progressive lung damage. We 
know that immahlrity of the lung, barotrauma, and oxygen toxicity contribute to the 
lung injury and the pathogenesis of chronic lung disease (CLD), but the exact 
mechanisms by which the lung undergoes severe disruption in struchlre and function 
arc not fully understood. The same holds tme for mechanisms preventing luug iItiury. 
Prolonged exposure to hyperoxia and barotrauma causes acute lung injury that leads to 
an inflammatory reaction. Capillaty pel1neability changes are amongst the first events 
to occur. The injmy process is initially characterised by an influx of cells, mainly 
neutrophils, and an elevation of the release of various inflammatolY mediators. This 
early inflammatOlY phase is followed by a subacute fibroproliferative response with 
fibroblast and smooth muscle proliferation, leading to interstitial and peri-alveolar 
fibrosis. Recent evidence suggests that the fibroproliferation response may be due to 
higher expression of different cytokines such as platelet derived growth factor-BB 
(PDGF-BB), tntnsfOlll1ing growth faetor-p (TGF-P) and interleukin-l p, produced by 
locally accumulated alveolar macrophages and probably epithelial cells. In some cases 
the inflammatOlY and fibroproliferation responses may lead to (development of) chronic 
lung disease (CLD). 
To investigate the pathogenesis of lung damage in the new-born, numerous at1iclcs 
have focused on the role of hyperoxia in this process, suggesting a complicated 
interplay between mcdiators and cells [10, 11, 13-17]. Besidcs hyperoxia models, 
another approach resulting in progressive tissue damage and remodelling is exposure of 
adult rats to a combiuation of ozone and nitrogen dioxide (N02) [18-22]. The effects 
are well documented, both at the biochemical level and morphologically. The 
consequences of exposure of adult animals to either N02 or Ozone have been 
published as well [23-30]. As other models for neonatal lung damage have proven to 
be a highly resistant to changes, such as hyperoxia, or are extremely expensive due to 
the complicated infrastructure needed, for example in the premature baboon model, a 
neonatal rat lung model was used. 
Inducing airway inflammation by damaging the airway epithelium air pollutants are 
thought to provoke asthmatic symptoms[31-33]. Nitrogen dioxide (NO,), is one of the 
major components of atmospheric air pollution that has been rep0l1ed to alter lung 
morphology and to affect pulmonary function [34,35]. Motphological changes after 
NO, exposure include damage to Clara, ciliated, and type-I epithelial cells in the 
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bronchioalveolar region [36,37], interstitial fibrosis [38], and increase in medial 
thickness of pulmonary arteries [39], indicating that NO, can cause lung remodeling. 
Furthenl1ore, these morphological changes are closely correlated with NO, 
concentration and exposure time [39]. Although many repmts have documented that 
nitrogen dioxide (NO,) can cause lung injury and ainvay remodeling in adults [36-39], 
virtually nothing is known regarding the effects of NO, exposure on the neonatal 
developing lung. 
A number of genes are expressed inl1l1ediately when cclls are snbjected to stress, 
stretch, and in case of acnte and chronic lung injmy [40,41]. Among these are the heat 
shock proteins (HSPs), a group of highly conserved proteins that can be induced by 
exposure to heat, as well as by a variety of pathophysiological conditions including 
hypoxia, oxidative and metabolic stresses [42,43). The HSP-70 family of proteins binds 
to adenosine tri-phosphate (ATP) and plays a role in the transport of proteins into the 
endoplasmic reticulum and mitochondria [44,45]. The small heat shock protein HSP-27 
is H 27 KDa stress related protein, considered a molecular chaperone expressed in 
developing organs. From cellular cytoplasm it migrates to the nucleus upon stress and 
plays a role in signal transduction and drug resistance [45,46]. HSPs have been repOlied 
to participate in embryonic and fetal development [47]. To onr knowledge, few studies 
have examined HSPs expression in NO, induced lung injmy and remodeling, 
paliicnlarly in the developing Inng. 
In order to establish the nature and time course of NO,-induced lnng damage in early 
life, we investigated the expression of mRNAs and tissue localization of HSP-27 and 
HSP-70 in a model of lung injury induced by chronic NO, exposure in weanling rat 
pups. 
6.2 Materials and Methods 
Experilllelliailllodei 
Specific pathogen-free, 3-days-old Wistar strain rat pups were used for this study. A 
total of 36 animals were divided into exposed and non-exposed (control) groups. 
Exposed pups were chronically exposed to NO, at 7 parts per million (ppm) for 8 hours 
daily for 7 days. Nitogen dioxide (NO,) was purchased from Hoekloos (Schiedam, the 
Netherlands) in a 500 g lecture bottle. The bottle was supplied with a T-conneetor with 
a septum. A series of two impingers was connected to the lecture bottle, with an end 
pressure of 4 cm water. After the cylinder was opened, it was heated using an ail' heater 
until all air in the system was replaced by (brown) NO, 111me. Then 70 ml off NO, 
vapor was sampled, under heating, into a 100 ml gas tight syringe, by repeated 
movement of the plunger. The animal exposure chamber (77x77xI25 cm +741 I) 
consisted of glass walls, an entrance, a gas inlet and sampling outlets. At the stali of the 
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exposure, the desired amount of NO, was injected into the chamber (see below). To 
maintain the desired concentration ,,,hile applying the necessary amount of fresh air 
into the chamber, the inlet (of the chamber) was connected to a Gilson personal 
sampling pump, which delivered fresh air at 1.2 l/min. Using a T-connector, a Braun 
innlsion pump was connected to the same inlet. Using this pump the gas tight syringe 
containing 100 ml NO, was emptied with the desired flow (see below). The 
temperature of the infusion pump was kept at 25°C with a re lamp. 
For 20 ppm of NO, : 20 x741II 000~15 ml of NO, was needed as a loading dose. With 
an air refresh rate of 1.2 mUmin, an additional amount of N01 was supplied. For this 
purpose, 20 ml of NO, per I, i.e. 24 ml per min~1.44 mllh, was theoretically needed. 
However, empirically it appeared that 4 mllh was necessary. This is due to loss of NO, 
to the walls, tubings, water vapour, animals etc. 
The NOz concentration in the chamber was determined using Drager indicator tubes: 
nitrous fumes 20/a 20-500 ppm. Sampling was performed at 5 min after start of the 
experiment, and each hour thereafter. \\Then necessary the N02 flow was adjusted to 
maintain the desired concentration. Using this system the NOz levels were well 
controlled: 
If aimed at 7 ppm: 7.0 ± 0.2 ppm 
If aimed at 20 ppm: 17.4 ± 1.3 ppm 
After exposure pups were allowed to recover for either one week (group I, 12 pups) or 
two weeks (group III, 12 pups). Following the recovelY period the animals were 
sacrificed. Age-matched controls were exposed to room air alone in the same way, 
forming two groups of 6 pups each (groups II and IV respectively). During exposure 
(periods), animals in each group were kept in a cage, which was placed in a gas-tight 
chamber equipped with an inlet for a mixture of N02 and compressed air. The N02 
concentration was measured and kept to 7 ppm. After exposure, all rat littermates were 
renll'llCd to room air for recovely. They were kept in conventional cages with their 
mothers and fed ad libitum until tissue preparation. The Erasmus University conunittee 
for research and animal studies approved all the experimental protocols. 
Tissue preparatioJl 
At day 7 (group I +II) and 14 days (group III + IV) after exposure, the pups in each 
group were anaesthetized by intraperitoneal injection of I ml sodium pentobarbital. 
Through a midsternal thoracotomy, extended to the cervical p0l1ion, both lungs and the 
trachea were exposed. For isolation of total cellular RNA, the two lungs were removed 
from the thoracic cavity, frozen in liquid nitrogen and stored at -80°C until analysis. 
For histological and immunohistochemical examinations, a 22G needle was inserted 
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into the trachea and the lungs Were fixed by injection of Davidson solution (40 vol % 
ethanol; 5 vol % acetic acid; 10 vol % formaldehyde; 45 vol % saline; pH7.3) at a 
pressure of 20 cmH20 [49]. Following lung expansion, both lungs and heart were 
removed as one preparation and immersed in Davidson solution for at least 24 hours 
and processed for the histology. 
[sofalioll oflolaf cellllfal' RNA alld NOl'lIIel'll bioi {/Jllt/ysis 
Total cellular RNA was extracted from 100 mg frozen lung tissue by the guanidinium 
thiocyanate-phenolchlorofonn method of Chomzynski and Sacchi [4S]. The RNA 
concentration was measured by spectro-photometry. For Northern hybridization, 10 pg 
of total RNA was denatured at 65'C in buffer containing fonnamide and ethidium 
bromide, and electrophoresed on 1% agarose gel containing 2.2M formaldehyde. The 
gels were photographed and RNA was transferred to hybond-N membrane (Amersham 
Nederland B. V., Den Bosch). Thereafter, filters were air-dried and UV cross-linked in a 
gene linker (Bio-Rad Laboratories B.V., The Netherlands). Blots were hybridized at 
42'C in a buffer containing 50% deionized fonnamide, 1.0 M sodium chloride, 1% 
sodium dodecyl sulfate (SDS), 0.2% polyvinyl pyrolidine, 0.2% ficoll, 0.2% bovine 
sen!ln albumin, 50mM Tris-HCI (pH 7.5), 0.1% sodium pyrophosphate, 10% dextran 
sulfate and denatured salmon spenn DNA (100 flg/ml). cDNA probes used for 
hybridization werc a 0.9 kb DNA fragment encoding human HSP-27, and a 2.1 kb 
DNA fragment encoding human HSP-70. cDNA inserts were labeled employing a 
multiprime labeling system (Amersham Nedcrland B.V., s'Hetogenbosch), to specific 
activity of 109 cpm/flg DNA using [32Pl-dCTP (3000 Cilmmol, Amersham Nedcrland 
B.V. Dcn Bosch). After ovemight hybridization, filters were washed at room 
temperature for 5 min in 2x SSC and 0.1 % SDS and at 42°C in O.lx SSC and 0.1 % SDS 
for 20 min. Subsequently, filters wcre wrapped in household plastic wrap and exposed 
to Kodak X-OMAT AR films (Kodak Nederland B.V., Odijk) at -SO°C for 24 hours. A 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe (1.2 kb Pst! 
fragment of human cDNA, procured from ATCC, USA) was used to rchybridize 
membranes for reference purposes. After performing autoradiography and 
densitometric measurement of signals, fold induction of gene expression was calculated 
and compared between different study groups. 
11111111111 oil is!ocllelll is!I'Y 
A fter Davidson fixation, the lungs were embedded in paraffin. Sections were cut at 6 
pm thickness and mounted on 3-amino-propyl-trioxysilane coated slides (Sigma, St 
Louis, MO, USA), followed by immunohistochemistry using the avidin-biotin complex 
(ABC) method. The sections werc dcparaffinized and endogenous peroxidase was 
quenched by 2 % hydrogen peroxide in methanol for 20 min. Non-specific binding 
sites were blocked by pre-incubation with 10% normal goat senun for 15 min. 
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Monoclonal mouse anti-human antibodies against HSP-27 {diluted 1:250} and HSP-70 
{diluted I: 100}(NeoMarkers, Frcmont, USA) were used as primary antiserum. The 
sections were incubated with primmy antisenlln at room temperature for 30 min. 
Negative controls were performed by omission of the primmy antiserum. A fter washing 
in 0.5% Tween in PBS solution, the slides were incubated for 30 min with mouse 
biotinylated anti-rabbit IgG (Multilink, 1:75) and with Peroxidase conjugated 
streptavidin in a dilution of 1 :50, both supplied by Biogcnex (San Ramon, MO, USA). 
Slides were visualized after developing the color using DAB (0,025% 3,3'-
diaminobenzine tetra hydrochloride dihydrate, Sigma, st. Louis, Mo, USA). Sections 
were counter stained with Mayer's hematoxylin. 
Sell/iql/{lIllilalil'e allalysis HSPs loc«lizalioll 
Expression ofHSP-27 and HSP-70 was analyzed semi-quantitatively and scored by two 
independent observers, using an arbitrmy visual scale ranging from 0 to 4: grade 0 
represents no staining, grade 1 represents focal staining, grades 2,3 and 4 represent 
diffuse weak, moderate, and strong staining, respectively [50]. 
Sialislical allalysis 
Results were calculated as mean ± SEM. Statistical analysis was based on thc unpaired 
Student's I test, and significance was accepted at P < 0.05. 
6.3 Results 
Expressioll ofll/RNAs ofHSPs 
By NOlihern blot analysis we detected mRNAs encoding both HSP-27 and HSP-70 in 
control as well as in NO, exposed rat tissues at 7 days after exposurc (Fig. I and 2). In 
control lungs, the Icvels of expression ofHSPs mRNA decreascd gradually. Howevcr, 
significantly enhanced expression levels (P ,; 0.05) of HSPs mRNA were detected at 7 
days after exposure (group I) and these levcls remained elevated until 14 days after 
exposure to NO, (group Ill) as compared to their respective controls (groups II and IV). 
Densitometric analysis of the blots revealed that expression levels of both HSPs were 
significantly elevated at 7 days after NO, exposure as compared to 14 days after 
exposure to NO, (Fig. 1B and 2B). Although, thc expression levels were decrcased in 
the pups at 14 days, their expression values were not statistically differcnt in controls 
and NO, treated groups. 
Hislology 
Hematoxylcnc and cosine staining assessed pulmonaty tissue histology in relation to 
N02 cxposurc. Routinc histological examination showed minimal differences between 
controls and NO, exposed groups (Fig. 3). However, N02 exposure resulted in partial 
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epithelial shedding in the tracheal ainvays of pups derived fi"Om group I and III (Fig 
3A). 
See color pictures 011 page 132. 
Tissue iocaii7;(Ilioll of HSPs 
Immunoreactivity for both HSPs was mainly localizcd in bronchial and bronchiolar 
epithelial cells in both experimental and control groups (Fig. 4 and 5). NO, exposure 
resulted in intense pulmonary staining for HSPs as compared to the control group at 7 
days after exposure. Intense staining of HSP-27 was detected in bronchiolar epithelial 
cells, and also in the adjacent alveolar type II epithelial cells of lungs in NO, exposed 
pups (Fig. 4). On the other hand, vascular smooth muscle cclls showed 
immunoreactivity of HSPs, which did not change drastically after NO, exposure (Fig 
4). Semi-quantitative analysis using a visual score revealed that the expression levels 
of HSP-27 and HSP-70 were reduced in rats at 14 days of exposure as compared to 
those after 7 days but still the values were higher than those ofthcir respectivc controls. 
See color pictures 011 page 134-137. 
6.4 DisCllssioll 
In the present study, we demonstrated enhanced expression of HSP 27 and HSP 70 at 
both mRNA and protein levels in NO, exposed lung tissues of neonatal rats. 
Histological evaluation rcvealed only minimal differences with controls. NO, is one of 
the most impOliant air pollutants, that are known to cause lung injmy and airway 
remodeling. NO, could be produced following oxidation of NO in the lung. In clinical 
circumstances, NO inhalation therapy has been used in neonatal patients with acute 
respiratOlY distress syndrome or persistent pulmonalY hypertension because of its 
vasodilator property [51). Although levels of NO, produced by NO therapy have been 
estimated to be as low as 2 ppm [52], they might induce injUlY, and exposing the lung 
to a stress condition. 
The effects of NO, on the capillmy alveolar scptal network and the phospholipid pool 
in the postnatal lung remodeling have been described previously [53). In addition, our 
present results point at to an impOliant role of NOrinduced airway inflammatOlY 
damage at a molecular level with the subsequent early pathophysiologic stages that may 
eventually account for the childhood asthma [31). These findings are supported in part 
by our findings of increased vascular endothelial growth factor (VEGF) at both mRNA 
and protein Icvels in newborn pups following chronic exposure to NO, [Sharma et al. 
Submitted]. 
Heat shock proteins are one group of the lung's defensive mechanisms, beside others 
such as the oxygen scavenger system including the antioxidant enzyme system [53,54). 
These mechanisms are of specific importance in cytoprotection and prevention of 
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parenchymal lung damage after exposure to certain injurious stimuli [55,56]. Our 
findings of increased expression levels of HSPs, which are known molecular markers 
of pulmonmy cellular stress [38,46,55], may indicate a possible role of HSPs in 
postnatal lung development and remodeling. Lung development in rats defines the 
formation of the main stmchlral lung tissue, including the capillary network in alveolar 
septa, which occurs within three weeks after birth [57]. Enhanced expression of HSPs 
in N02-exposed lungs might indicate its involvement in tissue protection and recovelY 
processes following NO,-induced injury in the developing lung. The expression levels 
of HSPs mRNA, which are maximal following the exposure and decreased by time, 
remained in this Shldy even significantly higher than in the respective controls, in 
correspondence to the protective role of HSPs in response to degree and time-peak of 
NO,-induced injmy. 
Immunoreactivity for both HSPs was mainly cytoplasmic, with minor degree of nuclear 
positivity, as has been reported previously [46]. Although previous studies showed 
histologic alterations in adult lungs exposed to NO, [36-39], our data could not support 
these findings as no remarkable changes in lung tissue at routine histological 
examination of neonatal lungs were seen. It remains unclear if the protective 
mechanisms against N02 exposure are more efficient in neonatal rats than in adults rats. 
OUf data show that N02 exposure induces a significant increase in the expression levels 
of HSPs genes, which had been reported to participate in cellular defense mechanisms 
and perhaps to enable the lungs to recover from stressful conditions [50]. Furthennore, 
the enhanccd expression of HSPs we found, represents a state of cellular injmy. HSPs 
are molecular markers of pulmonary stress, possibly triggering cytoprotective 
mechanisms against further pulmonary parenchymal damage, as demonstrated in 
previous reports on the eytoproteetive role of HSPs in both experimental and human 
tissues [58-60]. The enhanced expression of HSPs possible reflects a neonatal attempt 
to establish a protective mechanism against stress as shown earlier for antioxidant 
enzyme activity in a congenital diaphragmatic hemia rat model [60]. Interestingly, our 
results demonstrate that the bronchiolar epithelial cells exhibit the most intense 
expression of HSPs in the developing lung in response to N02 exposure, indicating 
cellular injmy, which is more pronounced in the distal airway passages. This is in 
accordance to a literature repmi documenting significantly raised expression levels of 
HSP-70 in inflammed ainvays in, for instance, asthmatic patients [61]. These findings, 
in view of the fact that in inflammatOlY airway diseases the distal bronchioli are the 
more affected ones, could explain that recurrent exposure to air pollutants in infancy 
heightens susceptibility to ainvay inflannnation at later life. A recent report 
demonstrates nasal mucosal inflammation following chronic exposure to low dose N02 
and ozone in humans in vitro [62]. One of the mechanisms underlying this notion could 
be that the distal air passages become hyper-responding or less protected against 
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inhalation injUlY. These findings could be useful in evaluating age-dependent changes 
and susceptibility of the pulmonary system to environmental pollutants.[ 63]. 
From the results of the current study and previous repOlis concerning the understanding 
of the pathogenesis of primary airway inflammatory disease, we hypothesize that 
neonatal rat lungs might have different cellular or functionally more efficient -already 
existing- defense mechanisms as compared to the adult rat lung. 
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6.5 Figures 
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Exp Con COil EXJl 
• ""CArOB=> 
7 Days 14 Oa)'s 7 14 
Days after N02 uposure 
(A) (B) 
Figure 1: Northel'll Blot analysis of HSP-27 mRNA in control and NO, exposed rat 
pups 
Total RNA isolated from pooled lungs from 3-4 pups from control as well as from NO, 
exposed groups was subjected to gel electrophoresis and subsequently for blotting and 
hybridization as descdbed in "Materials and Methods". Filters were hybridized with 
HSP-27 cDNA probe (Pallel A: upper part) and with GAPDH (Pllllel A: lower part). 
Autoradiography showed a single mRNA species of 0.9 kb encoding HSP-27 in the 
lungs of all pups. 
P(lIIel B: Bar diagram depicting relative mRNA levels of HSP-27 in control as well as 
in NO, exposed pups at 7 and 14 days of exposure. Note the induced expression of 
HSP-27 mRNA at 7 days of NO, exposure as compared to respective controls. Values 
are mean ± SEM from 3-4 different blots. P values of <0.05 were accepted as 
significant. 
'depicts significantly increased levels of HSP-27 mRNA as compared to respective 
controls. 
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Norhtem Blot Analysis of HSP-70 
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Figure 2: Northern Blot analysis of HSP-70 mRNAs in control and NO, exposed 
rat pups 
Total RNA isolated from pooled lungs from 3-4 rat pups from control as well as from 
NO, exposed groups was subjected to gel electrophoresis and subsequently for blotting 
and hybridization as described in "Materials and Methods". Filters were hybridized 
with a HSP-70 specific cDNA probe (Pullet A: upper palt) and with GAPDH (Pallet A: 
lower part) used for reference putposes. Autoradiography showed two mRNA species 
of3.5 and 2.7 kh encoding HSP-70 in the lungs of all pups. 
Pallet B: Bar diagram depicting relative mRNA levels ofHSP-70 in control as well as 
in NO, exposed rat pups at 7 and 14 days of exposure. Note the induced expression of 
HSP-70 mRNAs at 7 days of NO, exposure as compared to respective controls. Values 
are mean ± SEM from 3-4 different blots. P values of <0.05 were accepted as 
significant. 
'depicts significantly increased levels of HSP-70 mRNAs as compared to respective 
controls. 
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General Discussion and Concluding Remarks 
7.1 Introduction 
Congenital diaphragmatic hernia (CDH) is a congenital anomaly, which manifests itself 
in lout of 2000-3000 newborns [1-3]. Patients with CDH still experience a high 
mortality despite intensive medical and surgical treatment. This mortality is caused by a 
combination of pulmonary hypoplasia and persistent pulmonary hypertension [4,5]. 
Histopathologically, abnormalities in the pulmonary vasculature in CDH are well 
documented [6,7]. However, the exact causes attributing to the morphological changes 
and abnormal pulmonary vascular reactivity [8] are not fully understood inlleonates \vith 
pulmonary hypertension. In the clinical setting, most of the patients with CDH require 
artificial ventilation with high inspiratory pressure and high percentagcs of oxygen to 
provide adequate oxygenation in the immediate neonatal period, which is believed to be 
a main cause ofpulmollary sequel. It is not known whether and to what extent artificial 
ventilation and other environmental stress, not only in CDR but also in nonnai 
developing neonatal lungs, affect their developmental pattern. 
Air pollutants are thought to provoke ainvay inflammation by damaging the airway 
epithelium [9-11]. Nitrogen dioxide (NO,), is one of the major components of 
atmospheric air pollution that has bccn reported to alter lung mOlphology and affect 
pulmonary function [12,13]. MOIphological changes after NO, exposure include 
damage to Clara, ciliated, and type-I epithelial cells in the bronchioalveolar region 
[14,15], interstitial fibrosis [16], and increase in medial thickness of pulmonary arteries 
[17], indicating that NO, can causc lung rcmodeling. Furthermore, these morphological 
changes are closely correlated with NO, concentration and exposure time [17]. 
Although many reports had documented that nitrogen dioxide (NO,) can cause lung 
injury and airway rcmodeling in adults [36-39], virtually nothing is known regarding 
the effects of NO, exposure on the neonatal developing lung. Therefore the aim of thc 
shldies presented in this thesis were as follows: 
I. to investigate differences in pulmonary vascular development between hcalthy 
and CDH lungs in humans and a rat model; 
2. to investigate the expression patterns of vasoactive mediators in CDH lungs in 
an animal model of CDR; 
3. to evaluate the effect of insults such as different modalities of artificial 
ventilation and exogenous stimuli on stress response and vasoactive mediators 
in neonatal healthy and CDH lungs; 
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4. to examine the respons of neonatal rat lung parenchyma and the pulmonary 
vascular system during N02 exposure in an attempt to develop a model 
resembling the early changes in bronchopulmonary dysplasia. 
7.2 Inteqll'etation and implications of the studies 
7.2.1l11011J/lOlogical alld jUllctiollal plIlmollfllJ' !'asclIla/' flel'elopmellt 
In cases with CDR, a decreased number of pulmonary vessels, increased muscularity of 
the peripheral arteries and thickened adventitia have been repmted in the hypoplastic 
lungs. Such histopathological findings in man have also been confirmed in 
experimental rat and lamb models of CDR [18,19). Morin and Stenmark reviewed the 
nonnal structural development of the pulmonary vasculature with special attention 
towards the role of altered smooth muscle cell differentiation in the development of 
abnormal pulmonary tone [20). We have to take into account that the models used are 
the neonatal hypoxic calf model or rats exposed to hypoxia or hyperoxia after bitth. No 
detailed information is available on smooth muscle cell differentiation during abnormal 
pulmonary vascular development such as in case of CDR. For this reason ,ve 
examined the expression of myosin heavy chain isofol111S in pulmonary vascular 
smooth muscle in the rat model of CDR to evaluate the smooth muscle cell 
differentiation. The lungs of controls and those of rats with CDR showed similar 
patterns in the expression of SMemb, SM1, SM2 and alpha-actin, indicating that 
differences in smooth muscle cell differentiation do not account for the vascular 
abnormalities in CDR. Consequently a hampered differentiation of pulmonary SMC 
resembling on earlier phase of vascular development, in which high pulmonary 
vascular tone is a normal feature, can not be used as an argument. 
A number of different growth factors such as fibroblast growth factor, transforming 
growth factor-beta, platelet derived growth factor, insulin like growth factors I and II, 
and vascular endothelial growth factor (VEGF) have been shown by different 
techniqucs such as immunohistochemistry, in situ hybridisation during pulmonary 
vasculogenesis and angiogenesis [19-22). VEGF is an endothelial mitogen, which is 
regulated at the rcceptor level. Fms-like tyrosine kinase (Fit-I) and Flk-l are receptors 
for VEGF and are expressed during early vascular development in human embryos. 
VEGF has been shown to playa role in fetal angiogenesis, its expression increases at 
mid gestation to enhance angiogenesis and fOl1nation of vascular beds and decreases 
towards term. Many studies have been performed in different types of PR, where the 
expression of VEGF was found to be up regulated in persistent pulmonary 
hypertension of neonates (PPRN) [22-24). 
In our rat model of CDR, VEGF was detected in the vessels at the hilum and in 
parenchyma from gestational day 20 onward in control lungs, but it was absent in lungs 
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from CDR rats from day 16 to day 22. This finding suggests that decreased VEGF 
expression in Nitrofen induced CDR rat lungs accounts for altered endothelial cell 
growth. Recently the group of Shannon investigated expression of VEGF and its 
receptors in the Nitrofen rat model during prenatal development. These authors were 
not able to find diffcrences between CDR and control animals (Shannon, personal 
communication). We reported the enhanced expression of VEGF in small pulmonary 
vessels of CDR cases complicated with pulmonary hypertension as compared to their 
age-matched controls at the level of the SMC and endothelium. Our data indicate that 
there is persistence of thc stunted lung vessel growth in CDR cases as VEGF was 
repolied to be increased at mid-gestation in human fetuses. This is in accordance to the 
findings of Wiggleswotih and Desai who repotied that infants with lung hypoplasia in 
CDR bom at 34-39 gestational weeks have a lung cell population comparable to that of a 
normal fetus at 20-22 weeks. In our study, the increased expression possibly represents 
a fetal attempt to stimulate angiogenesis of the stunted bed in cases of CDR. 
We do not have a clear answer for this difference. Possible cxplanations may be that 
CDR rat pups were not exposed to hypoxic conditions during the experiment, or phases 
of lung development in utero are various among different species. It is also possible 
that the pathogenesis of the vascular changes induced by Nitrofen is very different 
from the Hnatural" course in the human fetus with CDR. 
7.2.2 Reglllllfioll o/pIIIIIIOII"':!' I'lISClIlul' fOlie 
In utero, the pulmonary blood flow is low and the pulmonary vascular resistance is 
high. Several factors modulating pulmonary vascular resistence in utero and during 
transition from intrauterinc to extrauterine life have been rcported [25-27]. Two 
factors, nitric oxide (NO) and endothelin-1 (ET-1), have been put forward as essential 
vasoactive mediators in the perinatal pulmonary circulation [25,28]. In lambs with 
CDR, a quantitative analysis showed no differences in the presence of endothelial 
nitric oxide synthase (eNOS) in the main pulmonary ariery tnlllks and controls [29]. 
However, quantitative studies of the lung parenchyma in rats with CDR showed that 
eNOS activity and the mRNA exprcssion were lower than in control lungs [30,31]. On 
the other hand, normal eNOS mRNA levels were reported in lungs of CDR rat pups 
which were not altered by prenatal treatment with dexamethasone [33]. Moreover, 
clinical observations show the reactions to a variety of vasoactive agents, including 
inhaled NO, to be highly unpredictable [8]. These findings leads us to investigate the 
expression ofET-1 and its receptors in CDR rat pups. Significantly enhanced levels of 
ET-J mRNA were observed in CDR rats compared with controls. In addition, a two-
to four fold increase in ET-A receptor mRNA were observed in CDR as compared with 
controls in contrast to equal levels of ET-B receptor mRNA. The upregulated 
expression of ET-1 and ET-A receptor mRNA may contribute to the pulmonary 
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vascular dysbalance in CDR. Furthermore, new trials of ET-A receptor blockade and 
ET-B receptor stimulation have been initiated in experimental CDI-I models as an 
intervention for pulmonary vasoconstriction in CDR with promising results (Mercier 
JC, personal communication). 
Our findings suppOli the pharmacological modulation of pulmonary vascular tone by 
ET-/ and ET-A blockade as an altemative treatment modality for CDR associated with 
persistent pulmonary hypertension. It is not known whether a dysbalance between the 
different isoforms of NOS and ET-l and its receptors is already present before birth. It 
is possible that the state of vasoconstriction before birth in an environment of low 
oxygen tension is mediated by a profound ET-I effecl. Developmental stndies in 
humans and rat models are essential in this respect. Evaluation of pulmonary vascular 
tone and respons on pharmacological agents in a standardised manner may provide us 
the necessary answers for future guidance of the proper vasoactive dmgs [33]. In 
addition, other experiments showed that the prevention of hypoxia by artificial 
ventilation including partial liquid ventilation decreased the expression of ET-l mRNA 
in control and CDR rat pups (unpublished observations). It will be necessary to search 
for the most effective combinations of pharmacological modulation and ventilatory 
strategy in the future. 
7.2.3 Tile effect of "insnlts" inneonutuiinngs 
7.2.3.1 Artificial venlilation including "Partial Liquid Ventilation" 
The use of ECMO has been advocated to prevent the lungs from being further damaged 
by mechanical ventilation and to correct PPHN [5]. The mean survival rate of CDH 
patients treated with ECMO has not improved markedly as compared with other 
ventilatory strategies, for instance high frequently oscillatory ventilation (RFOV) with 
NO [34,35], although some other centers using ECMO reported even higher survival 
rates [36,37]. Partial liquid ventilation (PLY) with perfluorocarbon has only recently 
been tried in humans, and the first results in adults, pediatric patients, premahlre babies 
with respiratory distress syndrome, and CDR patients are encouraging [38-40]. 
Previous repOlis shmved that lung compliance and gas exchange in infants and lambs 
with CDH improved significantly during PLY [40-42]. Especially the group of 
Lachmann (Rotterdam, the Netherlands) contributed significantly in the understanding 
of the positive effects of PL V on lung mechanisms; oxygenation and the combined use 
of PLY, NO and surfactant (reviewed in 43-45). However, the effect of stress at 
cellular and molecular levels, as a result ofPLV in CDH, has not been evaluated. 
We examined the changes in lung mechanics and the expression pattern of heat shock 
protein (RSP) - 70 and 27 as stress markers in control and CDR rats which underwent 
99 
Chapter 7 General Discllssion 
conventional ventilation (CY) and PLY in a randomized manner. Following PLY, 
increased total lung volume and improvement in opening pressure in CHD rats were 
observed. The expression of RSP mRNAs was enhanced after CY as compared with 
PLY. Our results clearly demonstrated for the existencc of endogenous defense 
mechanisms in hypoplastic CDR lungs and PL V appears to be lcss strenuous as 
compared to CY. These findings indicate that PLY may become a useful ventilatory 
modality for CDR patients and it may bc essential to define new ventilatory strategies, 
for instance the combination of ECMO and PLY (J.M.Wilson, personal 
communication). In this respect a thorough evaluation of the different therapeutic 
modalities available for the treatment of CDR patient is wananted. Besides the 
documented release of vasoactive mediators such as PGFI and TBX2 in rat CDR 
pups; cell counts and a number of inflammatory mediators in human CDR, almost no 
information is available [46,47]. The same holds tHle for the use of ECMO: lung rest is 
only a synonyme to hide our lack of knowledge. 
7.2.3.2 Siress responses in developing lungs 
The high incidence of chronic lung disease in surviving patients with CDR together 
with the well known clinical observations of the fast progression of altered lung 
morphology, resulting in adequate gas exchange in a number of patients were 
considered as arguments to perform these experiments. In fact two well-documented 
models are available in the literature: the premature baboon and the adult rat exposed to 
N02 and Ozone (03). In the premature baboon model bronchopulmonary dysplasia 
develops following atiificial ventilation. Especially the group of Coalson has 
contributed extensively to this model (reviewed in Bancalari) [48]. Due to the high 
costs of the animals, laboratory facilities and need for an animal intensive care one 
centre of research is at present active in the United States. 
For the rat 0 3 + N02 model special equipment is needed and facilities to control gas 
flow and environmental spread of noxious gas mixhlres. Thus far only in adult animals 
the combined use results in progressive lung fibrosis [49-52]. As described above, we 
investigated the expression of stress genes during artificial ventilation in CDR lungs. 
We extended our research to examine the expression of stress genes and the angiogenic 
growth promoter YEGF in developing lungs under stressful condition, i.e. nitrogen 
dioxide (N02) exposure. N02, is one of the major air components of atmospheric air 
pollution, was reported to alter lung morphology and affect pulmonary function. 
Previous studies on adults rats revealed that morphological changes in response to N02 
exposure include damage to Clara, ciliated, and type-I epithelial cells in the 
bronchoalveolar region, intestinal fibrosis, and increased medial thickness of 
pulmonary arteries, indicating that N02 can lead to lung remodelling. 
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We demonstrated that the expression of HSP-27 and 70 both at mRNA and protein 
levels were enhanced in chronic N02 exposed lung tissues than in control lungs of rat 
pups in spite of the observed minimal histological changes between both N02-exposed 
and control rats. This is indicated that the enhanced expression of HSPs also reflects a 
neonatal attempt to establish a protective mechanisms against stress as shown earlier 
for antioxidant enzyme activity in the CDH rat model [53). Regarding thc expression 
of VEGF under N02 exposure enhanced expression of VEGF in vascular smooth 
muscle, bronchial and bronchiolar epithelial cells in N02 exposed lungs as compared 
to controls was observed. These findings suggested that inducing VEGF expression 
under stress might contribute to vascular remodelling or initiate certain stmctural 
change at the stage of alveolar fOl1nation during lung development. However, our data 
are preliminary and further investigation will be required to evaluate stress response in 
developing lungs, particularly in hypoplastic CDH lungs. It will not be a simple choice 
to identify a key molecule in the complicated interaction of mediators. These 
mediators, locally produced or transfened from neighbouring cells, result in triggering 
the ongoing lung damage leading in a long lasting sequel and eventually fixed 
pulmonary damage. In this respect predetermined evaluation of stress markers in 
routine performed bronchoalveolar lavages might be helpful in this respect in the 
clinical situation. The question remains whether information obtained from BAL-fluid 
is a true representative of the changes occurring in the lung parenchyma. 
7.3 Concluding remarl{s 
Although many aspects of lung hypoplasia and persistent pulmonalY hypertension in 
CDH have been shldied, many issues remain to be clarified. The use of different 
animal models and patient selection of human cases (autopsy material) with CDR has 
revealed confusing and sometimes contradictory data. However, we need to elucidate 
these results and to implicate these in our clinical daily practice. A complete 
understanding of the pathogenesis of lung development of CDH and of those factors 
that contribute to lung injury eventually determine the prenatal, prenatal and postnatal 
management of patients with CDH. Especially the latest achievements in treatmcnt 
modalities such as prenatal tracheal plugging and the use of corticosteroid after 
prenatal diagnosis (CDH study group) warrants careful, well prepared and documented 
evaluation [54-56]. In this thesis, we proposed some therapeutic strategies such as 
endothelin blockade and PL V. In addition, recently beneficial effects of prenatal 
hormonal modulation in CDH have been reported in the rat model of CDH [57,58]. 
However cxact mechanisms of these effects still remain unknown. The large number 
of suggested interventions illustrate that we still have not found thc ultimate solution 
how to manage the fragile hypoplastic lung and lcthal persistent pulmonary 
hypertension in CDH. 
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Chapter 8 
8.1 Summary 
Neonates with congenital diaphragmatic hernia (CDR) experience a high mortality due 
to pulmonary hypoplasia and persistent pulmonary hypertension (PPHN) despite 
intensive mcdical and surgical treatment. To clarify the exact mechanisms of 
pulmonary hypoplasia and PPHN is essential to achieve advancements in the 
management of neonates \vith CDR. This thesis was undertaken in order to investigate 
the mechanisms of abnormalities of the pulmonary vascuiahlre and the abnormal 
pulmonary vascular reactivity. Furthermore, we included our studies on the pulmonary 
stress responses in developing normal and hypoplastic CDH lungs. 
This thesis consists of five parts: Part I (Chapter 1) is the general introduction 
including thc objectives of thc thesis. Part II (Chapter 2 and 3) describes studies 
foclising on pulmonary vascular development and Part III (Chapter 4) is a study about 
control of pulmonary vascular tone. Part IV (Chapter 5,6) consists of studies focusing 
on pulmonary stress responses in developing lungs in two different rat models of CDR 
and CLD. Lastly, Part V (Chapter 7 and 8) includes thc general discussion and 
concluding remarks as well as the summary of the entire work included in this thesis. 
Chapter I gives a review of the literature concerning CDH research including recently 
applied aspects of molecular biological techniques and introduces the subjects of this 
thesis. 
In the next two chapters, we investigated pulmonary vascular development in CDR 
and control lungs. In chapter 2, we examined the expression of a potent angiogenic 
growth promoter, vascular endothelial growth factor (VEGF), and myosin isoforms in 
a Nitrofen induced rat model of CDH. Myosin heavy chain (MHC) isoforms such as 
Swfemb, SM! and SW12 are important molecular markers used to ShIdy vascular 
smooth muscle cell differentiation. Differences in expression pattern of wfRC 
isoforms betwecn CDH and control rat lungs during gestational day I G to 22 (term) 
were not observed, VEGF was positive in pulmonary vessel walls from gestational day 
20 in control rat lungs in contrast to absent eX{Jression of VEGF during gestational day 
1 G to 22 in CDH rat lungs. These findings suggest that pulmonary vascular 
development differ between COH and control rat lungs. Altered endothclial cell 
growth might be related to the different pulmonary vascular reactivity in CDR. In 
chapter 3, we examined the expression of VEGF in human cases ,vith CDH and 
controls. In contrast to the findings from the Nitrofen induced rat model of CDR, the 
VEGF expression in the pulmonary vasculature of infants who had died from CDR 
was increased, especially in the small, pressure-regulating pulmonary mteries, as 
compared with that in lungs of control patients. Although these two chapters suggest 
that VEGF plays an important role in angiogenesis and in vascular remodelling in 
cases with CDR, fUliher investigation at gene regulation level is warranted to explain 
these differences. 
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Chapter 4 is a description of one aspect of pulmonary vascular tone in CDH. The 
background consists of previous repOits of different expression pattems of nitric oxide 
synthase (NOS) in cxperimcntally induced CDH lungs and unpredictable responses 
against inhaled nitric oxide (NO) in patients with CDH. For this reason we examined a 
potent vasoconstrictor and a mitogen for vascular smooth muscle cells) Endothelin-I 
(ET-l), and its receptors using a rat modcl of CDH. Significantly enhanced levels of 
ET -1 mRNA were observed in CDH rats compared with control rats. In contrast to 
equal levels of ET- B mRNA) a two to fourfold increase in ET -A mRNA levels was 
observed in CDH compared with control rats. The upregulation of ET-I and ET-A 
receptor mRNA in CDH rat lungs at term indicates that this peptide plays an important 
role in pulmonary vasoconstriction and altered pulmonary vascular muscularization in 
CDR. We speculate that thc use of endothelin blockade for the managemcnt of PPHN 
should be considered against the background of the unpredictable and variable 
response to inhaled NO in patients with CDH. 
In chapter 5, we report thc effects of patiial liquid ventilation (PLV) in CDH and 
control rats with regards to lung mechanics and cellular and molecular adaptation 
using heat shock protein (HSP)-70 and 27 as stress markers during ventilation. 
Following 4 hours of PLV increased total lung volumc in both control and CDH rats 
and improvement in opening pressure in CDH rats were observed as compared to rats 
with conventional vcntilation (CV). Both mRNA and protcins of HSP-70 and 27 werc 
detected in control and CDH rat lungs on gestational day 22 (term). Furthermore, 
significantly enhanced levels of HSP-70 mRNA were observed in CV rats as compared 
to PLV rats in both control and CDH lungs. However, the expression of HSP-27 
mRNA was enhanced in CV rats as compared to PLV rats only in control group. We 
concluded that endogenous defence mechanisms in hypoplastic CDH lungs arc not 
developmentally retarded and that PLV appears to be less strenuous as compared to 
Cv. 
To evaluate pulmonary vascular stress responses in developing lungs) we investigated 
the expression of HSP-70 and -27 and VEGF in newborn rat lungs after acute or 
chronic nitrogcn dioxide (N02) exposure. Chapter 6 dcscribes the exprcssion of HSPs 
in lungs after chronie exposure to N02. After 7 days exposure to 7 pUliS per million 
(ppm) N02 to 3 days old rat pups showed signitlcantly enhanced levels of HSPs 
mRNA up till 14 days after exposure as compared to non-exposed control rat lungs. 
Histologically, although no apparent differences betwcen N02 exposed and control 
lungs were seen at routine histological examination level) intense HSPs 
immunoreactivity was observed in N02 exposed rat lungs as compared to controls. 
These findings suggest that HSPs reflect a neonatal attempt to establish a protective 
mechanism against stress in developing lungs. 
In conclusion, congenital diaphragmatic hernia is 011e of the major challenges for 
paediatric surgeons and neonatologists. .Many questions still remain to be answered 
concerning the exact mechanisms of lung hypoplasia and PPHN in relation to various 
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unpredictablc responses against medical and surgical managcment to the prevention of 
ongoing lung injury. The information in this thesis may guide new strategies of 
modulating pulmonary vascular tone and prevention of ongoing pulmonary damage. 
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8.2 SnmellYfittillg 
Pasgcborenen met congcnitale hernia diafragmatica (CHD) hebben een hogc 
sterftekans door het optreden van pulmonale hypoplasie en persisterende pulmonale 
hypertensie (PPHN), ook bij intensieve medische en chirurgische behandeling. Dit 
proefschrift beschrijft onderzoek naar mogelijk onderliggende afwijkingen in het 
pulmonale vaatstelsel en in de vasculaire reactiviteit in de longen, alsmede ondcrzoek 
naar de reactie op stress in zich ontwikkelende normale en hypoplastische longen bij 
CHD. 
Hoofdstuk 1 gecft een overzicht vall de litcratuur betreffende onderzoek naal' CHD, 
met inbegrip van recent toegepaste moleculair-biologische techllieken, en introduceert 
de ondenverpen die in dit proefschrift behandeld worden. 
De volgende twee hoofdstukken gaan in op de vaatontwikkeling in CHD- en 
eontrolelongen. Hoofdstuk 2 behandelt de expressie van VEGF, cen bclangrijke 
vasculaire endotheel groeifiletor, en van myosin heavy chain (lv/He) iso/arms in rattcn 
met CHD opgewekt door Nitrofen. De expressie vanliJHC is~rorllls tijdens dag 16 tot 
22 (term) van de ontwikkeling voor de gCb00l1c verschilde niet tussen CHO- en 
controlelongen, tcrwijl VEGF positief was in pulmonale vaatwanden vanaf dag 20 in 
controlelongcn, maar niet in CHO-Iongen gedurende dag I G tot 22. Oit doet 
vennocden dat de vaatontwikkeling in CHD-longen verschilt van die in normalc 
longen. De afwijkende endotheelcelgroei zou verband kunnen hebbcn met de 
afwijkendc pulmonale vasculaire reactiviteit bij CHD. Hoofdstuk 3 behandelt de 
expressie van VEGF in kinderen met CHD en in controlepatienten. In tcgenstelIing tot 
wat we bij ratten hadden gevondcn, was hier sprakc vall verhoogde expressie - in 
vergclijking met controiepatienten - van VEGF in het pulmonale vaatstelsel van 
kinderen die tengevolge van CHD waren overleden, vooral in de kleil1e 
drllkreglilerende longslagaders. Of schoon de bevindingen uit deze twee hoofdstukken 
daen vermaeden dat VEGF een grate rol speelt in de angiogenese of de vasculaire 
hermodellering in geval bij CHO, dient nader onderzoek te wordcll verricht 0111 de 
verschillen tc kunncn verklaren. 
Hoofdstllk 4 besehrijft een aspcet van de long"aat!onus bij CEO. Eerder besehreven 
afwijkende expressie van stikstofoxide synthase in de longen van proefdieren, en 
onvoorspelbarc reacHes op ge'inhalecrde stikstofoxide bij kindcren met CHD vormden 
een aanleiding om de rol van Endothelin-I (ET-I) en Endothelin-reeeptorcn te 
bestuderen in rattcn met CHD. Significant hogere concentraties ET-l I11RNA \verdcn 
waargenomen in CHD mtten in vergelijking mct controleratten. Dc concentratics ET-B 
mRNA \varen gelijk, maar in CDH ratten waren de ET -A mRNA concentraties twee tot 
vier maal zo hoog als bij controleratten. De bevindingcn duiden op een grote rol van 
dit peptide in de vasoconstrictie en in de vaatspierontwikkeling in CDH-Iongen. Va or 
de behandcling van PPHN kan, gezien de onvoorspelbarc en varia be Ie reacties op 
gelnhaleerd stikstofoxide bij patienten met CHO, een endothelineblokkade worden 
overwogcn. 
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Hoofdstuk 5 besehrijft de ui(werking van partial liquid ventilalion (PLY) ap 
longmechanismen en cellulaire ell moleculaire adaptatie in ratten met en zonder CHD. 
Na 4 uur PLY was in beide het totalc longvolume toegenomen, en 'vas de 
openingsdruk in ratten met CDR verbeterd ten opziehte van ratten die conventioneel 
waren beademd. BepaaJde eiwitten die een rol spelcn bij de afweerreactie, heat shock 
proteins genaamd, werden waargenomcn in de longen van CHD- en controleratten a 
tenne. Bij ratten die conventionccl beademd waren, werden significant hogere waardcn 
van een van dc beidc stressmarkers waargenomen. De bevindingen van dit onderzoek 
geven aan dat de endogene defensiemechanismen in hypoplastisehe CHD-Iongen niet 
een vertraging in de ontwikkeling hebben opgelopen, en dat PLY mindel' belastend is 
dan eonvcntionele beademing. 
Tn hoofdstuk 6 wordt een onderzaek beschreven naar de vasculaire strcss rcacties in de 
zich ontwikkclende Iangen van pasgcboren mtten na acute of ehrollischc blootstclling 
aan stikstofdioxide (N02). De longen van rattcn van drie dagen oud werden 
bIootgesteld aan 7 per miljaen (ppm) deIcn N02 vertaanden significant hagere 
concentraties van de markers tat 14 dagen dam-na, in vergelijking tot de longcn van 
ratten die niet aan N02 waren blootgestcld. Histolagiseh werd in de longen van aan 
N02 blootgestelde ratten stefkc imll1unorcactiviteit van de markers vastgesteld. Deze 
bevindingen do en vermocdcn dat er in de zich ontwikkclende longen cen beschermend 
mcehanisme tegen stress wordt gevormd. 
Tenslotte, congenitale hernia diafragmatica bIijft een grotc uitdaging voor 
kinderchirurgen en nconatologen. Er zijn nog vele vragen over de prccieze 
mcchanismen die cen rol spelen bij langhypoplasie en PPHN, over de uiteenlopende 
en onvoorspclbal'e reacties op mcdisehe en chil11rgische behandelingcn, en over het 
voork6men van blijvende longschade. De gegevens uit dit proefsehrift kunnen wellicht 
als richtsnoer dienen bij nieuwc strategieen voor het modulercn van de Iongvaattonus 
en het voork6men van blijvende longschade. 
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ColouI' PictuI'es 
Page 25: 
Figllre 1. (A) Expression ofVEGF is not seen in the vessel walls in a CDH rat at day 
20 iml11unostained for Ab VEGF and cOllnterstnined with haematoxilin (original 
magnification x 400) 
(8) Moderate to strong expression of VEGF (arrows) in the vessel walls in a control 
rat at day 20. Immunostaining as in Fig IA (original magnification x400) 
Figllre 2 (A) Strong expression of SMemb (arrow) in smooth muscle cells in the 
vessel in a CDH rat at day 16 illllllullosiaincd for Ab SMcmb and counterstaincd with 
haematoxylin (original magnification x I 00) 
(8) Expression of SMcmb is not seen in the vessel walls in a CDH rat at day 22 
imll1Ul1ostaincd for AB SM2 and coullterstained with haematoxylin (originnl 
magnification x400). No differences in a control lung were observed. 
Figllre 3 (A) Strong expression of alpha-actin in the smooth muscle cells in the vessel 
walls and in the airways in a CDH rat at day 18 immullostained for Ab alpha-actin and 
CQlInterstaillcd with hacmatoxylin (originalmagllificatioll x400). 
(B) Strong expression of alpha-actin in the smooth muscle cells in the vessel walls and 
in the airways in a control rat at day 18. Imlllullostaining as in Fig 3A (original 
magnification x400) A,ainvay; V, vessel. 
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Page 35: 
Figure, 1: Tllllllllllohistochcmicallocalizatioli of VEGF ill the humall Illng tisslle. 
\Vhcrc: A; in tense express ion of VEGF ill the medial smooth muscle cells of small 
diameter pulmollm) ' arteries and ill the bronchial epitheliulll of CDH lung tissue, B; 
expression ofVEGF in the bronchial epitheliulll and faint ly in the smooth IllllSC Ie cells of 
the pulmonary arte ries of control non-hypoplnstic lung tissue, C; expression of VEGF ill 
the at1erial endothelium (arrow) and mcdial smooth muscle cel ls of pulmonary m1erics in 
CDH hypoplast ic lung tissue, and D; arterial endotheliulll identified (arrow) by CD31 
stnining lIsing peroxidase tcchnique. [Calibration bars = 50 pill in A and B and 25 pill in 
C and D]. 
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Page 67: 
Figllre 3: i'lIlmollary histo logy ill cOlltrol alld CDJ-I rats after CV alld PLV 
For histological examination, lungs were fixed, embedded in paraffin and processed for 
the routine Hematoxylin-Eosin stain ing to assess the lung histology. N ote <In alveolar 
aeration-pattern in control rats (Panel A) and a centro-acinar aeration pattern in CDH rats 
(Panel B). An improved aeration pattern could be seen after PLV in both control and 
CO l-! rat IlIIIgS (Panel C and OJ. 
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Page 68: 
Figure. 6: TmnHlllohistochemiral localization of HSP-27 in CDH and control rat lun gs 
subjected to C V or PL". 
Paraffin secti ons of 6 ~1111 were stained lIsing alkaline phosphatase method as described in 
"M aterials and j\llcthods". N ote the imlllulloreactivity for I-I SP-27 in Bronchial cpithelium 
and medial SMC of (A) contro l ra ts with CV, (13) CDH ra ts with CV, (C) con tro l ra ts wi th 
PLY and (D) CD H rats with PLV. Panel E depicts the loca liz" tion of a-smooth muscle act in 
in the bronchial as well as vascular smooth muscle cells, whereas, panel F shows the negative 
control prepared by omitting the primary antibod ies ill staining protocols in order to verify the 
specificity and background staining for our I-I SPs antibodies. (Nlagnification X 400). 
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Page 68 : 
Figllre. 7: Immliliohistochemical localizatioll of HSP-70 ill CDH alld cOlltrol rat 
IIIIIgs sllbj ected to CV or PLV. 
6 pill thick paraffin embedded tissue sections were stained using peroxidase method as 
described in "Material s nnd Methods". Note the Imlllunoreactivity for HSP-70 was seen in 
brollchial epithelillm and medi"1 smooth musclc cells of (A) cont rol rats with CV, (8 ) CDH 
rats with CV, (C) control rats with kept on PLV and (D) CDH rats snbjected to PLV. 
;vlicrophotogrnphs were taken at the magnification or 400 X. 
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Page 83: 
Figure 3: Histologica l examination of tracheal rings obtailled from control and NO l 
exposed ral pllpS 
Trachen l rings obtained from control (panel A) as well as fi 'olll NOl exposed rat pups 
(pancl B) were fixed in formalin and embedded in paraffin. 5 p tissue sections were 
stained w ith hClllotnxylin-eosill ,mel visua lized under light microscope. Note the partial 
epi thelia l shedding in the NOl exposed rat pups. Ivlagni fi ca tion X 200. 
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Figure 4: ImllluJlochcmistry for HSP-27 ex pression in the lung tissue's obtained 
rrom control and NO l exposed rat pups 
Immunohistochemical loca lization of HSP-27 in the developing rat lungs obtained from 
control rat pups and exposed to N01 gas was performed as described in the ""Materia ls 
and Methods", Microphotographs show pulmonary specimens OrNal exposed rat pups 
after 7 days o f recovery (A); after 14 days of recovery (8); from 7 days age matched 
non-exposed control rat pups (C). Panel D depicts the negative control where the 
primary antibody was omitted. Note the epithelial and vascular smooth muscle staining 
for HSP-27 in N01 exposed rat pups. Magnification was set at X 200. 
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Page 83: 
Figllre 5: Immlllloehem ical localizatioll of HSP-70 ill the developillg IlIlI gs 
obtailled from cOlltrol alld NO l exposed rat pups 
Immullohistochcmistry for thc ex pression of J-ISP-70 in the developing rat lungs 
obtained frolll control rat pups and those exposed to No.2 gas was performed as described 
in the "Material s and rvlethods". iVlicrophotographs show pulmonary specimens of No.2 
exposed rat pllpS after 7 days of recovery (A); after 14 days of recovery (B); from 7 days 
age matched lIon-cxposed control rat plipS (C). Pancl D depicts the negative control 
where the pri mary antibody was om itted. Note the epithelial and vascular smooth 
muscle stai ning for H SP-27 in NOl exposed rat pups. rvIClgni(i ention was set at X 200, 
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